Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
ADGRG6	"FLJ14937, GPR126"	ENSG00000112414	"Adhesion G protein-coupled receptor G6"	Q86SQ4	6	142301854-142446266	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 71.9;placenta: 47.4"	"Cell type enhanced"	"Detected in many"		"Endothelial cells: 41.7;Hepatocytes: 143.8;Kupffer cells: 40.5;Pancreatic endocrine cells: 37.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 88.6;Hep G2: 84.8;hTERT-HME1: 81.5;HUVEC TERT2: 161.4;MCF7: 155.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA017346	Approved					NA	NA		110000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"			"HPA017346: AB_1849260"	"unprognostic (1.04e-2)"	"unprognostic (2.72e-2)"	"unprognostic (7.37e-2)"	"unprognostic (3.00e-2)"	"unprognostic (8.64e-4)"	"unprognostic (1.67e-1)"	"unprognostic (2.98e-1)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (2.78e-5)"	"unprognostic (4.46e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.97e-2)"	"unprognostic (4.59e-2)"	5.8	2.8	2.6	4.1	2.3	0.4	5.2	1.6	1.9	3.0	1.9	6.2	17.5	1.1	1.3	11.6	5.2	8.3	4.0	1.8	1.7	7.2	71.9	15.2	1.7	2.4	2.9	1.4	3.2	1.3	0.3	47.4	2.2	3.2	6.4	0.1	9.0	6.5	0.5	14.5	10.2	2.2	2.5	7.5	12.3	2.1	4.6	4.6	1.6	1.2	4.0	15.1	5.6	1.9	17.0	88.6	1.9	9.4	0.5	0.0	0.2	23.1	4.3	17.2	10.7	71.3	51.0	0.0	20.3	13.4	4.9	41.3	2.6	22.1	28.3	0.0	6.8	3.6	14.5	84.8	16.7	14.6	0.0	0.1	34.9	0.4	81.5	10.0	161.4	0.4	0.6	0.1	6.9	155.6	0.3	0.0	0.7	6.2	20.0	0.0	7.7	17.7	9.0	37.9	0.1	0.1	6.8	30.8	14.5	14.1	16.7	0.3	5.6	0.1	7.6	7.7	11.5	0.0	0.1	0.0	0.1	0.1	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.3	1.6	1.9	1.8	1.7	2.4	2.9	2.2	2.5	4.6	1.9	5.1	6.4	5.9	0.0	0.3	0.0	21.9	0.0	18.8	0.0	5.3	2.7	1.9	24.3	8.1	9.2	0.0	5.3	0.0	0.6	0.0	13.2	0.1	0.1	0.5	41.7	0.0	17.0	1.6	5.4	33.5	14.5	32.1	0.5	0.0	0.0	27.1	143.8	2.2	0.0	12.7	3.5	0.0	40.5	0.0	0.6	0.6	8.1	0.0	15.0	0.9	0.0	0.0	0.5	0.3	37.9	8.8	0.4	0.1	18.7	9.5	11.8	2.9	0.0	6.6	0.4	1.3	2.6	5.3	30.2	0.0	13.5	1.6	0.0	1.7	25.0
ADGRL3	"KIAA0768, LEC3, LPHN3"	ENSG00000150471	"Adhesion G protein-coupled receptor L3"	Q9HAR2	4	61201258-62078335	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3"	"Group enriched"	"Detected in many"	11	"Astrocytes: 584.1;Excitatory neurons: 696.1;Inhibitory neurons: 737.4;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 592.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 41.8;EFO-21: 10.8;HEK 293: 6.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015027, HPA015762, CAB022698"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245"	"unprognostic (2.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.23e-3)"	7.1	6.2	25.1	1.1	25.7	0.0	2.5	14.0	30.7	5.5	0.0	4.0	2.5	3.9	1.8	1.0	2.4	1.6	2.6	30.4	25.0	1.6	0.4	2.6	0.4	15.3	24.6	1.1	0.3	6.7	0.9	1.2	15.9	1.3	3.9	10.0	0.6	4.2	0.7	3.0	3.6	3.0	12.5	0.3	3.2	4.1	32.3	0.4	0.7	0.3	0.1	1.6	3.4	15.7	0.0	0.1	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	3.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.0	0.0	4.0	0.5	0.1	0.1	0.0	4.8	0.2	0.0	6.3	0.3	0.0	0.0	0.0	7.6	0.1	3.2	0.0	0.2	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	25.7	14.0	30.7	30.4	25.0	15.3	24.6	15.9	12.5	32.3	15.7	0.4	0.0	0.0	584.1	0.0	0.0	0.0	0.0	0.6	12.4	4.9	1.8	3.3	0.0	0.0	0.0	4.2	1.0	0.0	0.0	9.8	0.0	46.4	1.3	17.7	1.9	0.0	0.0	696.1	0.0	1.3	3.3	0.0	0.4	0.0	0.4	2.5	0.2	0.1	1.7	737.4	0.0	0.0	0.0	0.0	33.2	0.0	0.5	0.0	70.3	0.0	31.3	0.0	1300.8	592.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.4	6.6	0.3	18.5	0.9	3.5	1.2	0.0	2.2	0.2	0.1	0.0	0.1
AIG1	"AIG-1, dJ95L4.1, FLJ10485"	ENSG00000146416	"Androgen induced 1"	Q9NVV5	6	143060496-143341058	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 235.8"	"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 245.4;Proximal tubular cells: 261.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060766	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA060766: AB_2684356"	"unprognostic (2.70e-2)"	"prognostic unfavorable (3.26e-6)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.25e-7)"	"unprognostic (1.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.75e-1)"	42.0	29.8	43.7	10.4	44.6	31.6	30.0	43.3	46.1	17.6	48.2	23.0	46.6	14.4	33.0	34.1	34.4	24.5	54.1	44.1	49.1	102.0	235.8	19.9	10.7	45.0	43.4	34.7	31.0	31.0	36.6	11.9	46.4	22.7	18.8	33.9	19.8	24.1	23.7	16.8	45.9	15.2	47.1	20.1	20.8	15.7	51.0	6.8	42.9	32.5	14.8	29.4	26.1	52.5	32.6	25.2	20.6	56.9	29.7	22.3	7.6	28.3	57.1	26.8	61.9	37.5	81.5	20.0	40.5	66.1	41.7	42.0	26.5	79.2	64.2	67.2	63.0	5.6	35.6	157.3	40.8	46.0	2.7	32.9	76.7	35.7	129.6	88.2	10.9	30.8	4.0	67.6	59.3	45.6	14.2	9.8	40.8	37.4	27.6	20.2	61.6	36.6	100.6	77.6	75.5	42.4	35.5	33.2	17.2	36.0	31.7	96.0	3.0	25.2	27.8	22.7	33.4	99.6	95.1	2.1	59.7	9.5	26.9	12.0	6.2	9.6	6.6	29.3	15.1	9.6	12.4	10.6	33.0	5.6	13.1	10.0	11.3	11.8	35.4	2.9	9.7	9.2	43.7	44.6	43.3	46.1	44.1	49.1	45.0	43.4	46.4	47.1	51.0	52.5	40.8	16.0	27.7	114.9	22.0	25.0	51.8	82.5	27.9	68.3	69.9	65.4	73.7	72.9	66.9	51.5	25.0	79.6	8.6	12.6	52.8	60.3	22.4	99.8	25.9	32.8	39.5	29.3	204.3	31.5	10.5	42.2	26.0	83.1	36.8	90.9	36.8	229.6	32.7	53.8	245.4	33.3	59.0	40.1	42.3	7.0	32.0	37.2	55.2	100.2	18.2	74.3	8.2	105.1	172.9	25.8	65.2	38.4	47.7	35.3	232.9	261.5	69.1	36.9	32.9	41.7	50.8	5.6	17.3	53.1	45.7	108.1	18.5	61.5	42.4	53.2
ANK2	"CFAP87, FAP87, LQT4"	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818032-113384221	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 165.7;retina: 191.2;skeletal muscle: 171.7;tongue: 150.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1101.2;Bipolar cells: 376.6;Cone photoreceptor cells: 479.6;Excitatory neurons: 1282.0;Horizontal cells: 1431.8;Inhibitory neurons: 1060.7;Oligodendrocyte precursor cells: 497.1;Oligodendrocytes: 1351.0;Rod photoreceptor cells: 484.4"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 32.2;RH-30: 49.6;SH-SY5Y: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	31.0	13.6	94.9	11.2	109.0	0.1	18.3	63.1	165.7	31.6	0.0	30.1	8.5	15.8	5.9	12.9	9.6	22.5	119.5	103.9	77.5	110.1	2.4	7.2	9.2	130.2	61.1	27.3	3.2	1.2	19.3	2.1	119.5	7.8	11.4	191.2	6.7	13.3	171.7	8.7	12.7	24.9	51.9	28.3	8.3	9.4	84.8	4.4	9.6	150.5	7.2	9.5	12.3	116.2	0.1	2.9	18.7	5.2	29.2	32.2	0.1	1.5	3.4	0.9	2.6	4.2	0.0	6.9	2.1	5.9	4.1	0.1	11.0	0.6	1.0	2.3	7.3	4.0	0.0	2.9	1.7	1.9	1.2	15.2	3.0	1.2	6.0	3.9	0.0	0.4	0.0	9.3	5.8	0.3	0.2	0.1	9.4	0.1	2.0	0.7	49.6	0.0	0.2	0.0	13.6	24.1	0.2	0.7	8.1	11.7	0.1	1.1	0.0	4.7	2.2	0.4	3.0	6.8	1.8	0.9	20.1	0.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	109.0	63.1	165.7	103.9	77.5	130.2	61.1	119.5	51.9	84.8	116.2	6.9	0.0	3.9	1101.2	1.1	10.5	0.0	0.0	1.8	376.6	0.2	0.6	188.5	0.0	1.3	20.2	479.6	0.1	0.0	0.0	15.6	0.0	111.2	36.4	6.0	6.4	66.0	0.0	1282.0	1.6	0.1	79.0	2.0	7.2	1.3	81.8	0.0	0.4	1.0	1431.8	1060.7	0.4	8.2	0.0	19.7	49.8	36.4	2.9	17.8	90.9	0.6	44.5	0.0	497.1	1351.0	0.1	5.0	30.1	0.9	0.4	0.1	127.9	0.8	484.4	6.6	24.3	26.5	2.3	1.5	0.8	9.5	0.0	1.9	2.6	0.3	0.2
ANOS1	"ADMLX, KAL, KAL1, KALIG-1, WFDC19"	ENSG00000011201	"Anosmin 1"	P23352	X	8528874-8732137	"Disease related genes, Human disease related genes, Predicted secreted proteins"	"Cell adhesion, Chemotaxis"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Disease variant, Hypogonadotropic hypogonadism, Kallmann syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 43.1"	"Cell type enriched"	"Detected in many"	11	"Alveolar cells type 1: 240.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"hTERT-RPE1: 40.4;NTERA-2: 37.0;U-2 OS: 17.6"					"Low region specificity"	"Detected in all"								"Secreted in brain"	NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (2.93e-1)"	"unprognostic (5.33e-2)"	"unprognostic (9.54e-2)"	"unprognostic (4.16e-3)"	"unprognostic (7.77e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.17e-3)"	"unprognostic (4.53e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.09e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.38e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.56e-2)"	6.6	4.0	7.6	1.1	10.5	0.3	3.7	6.0	7.3	4.4	0.9	0.6	0.3	0.5	3.1	1.3	1.1	1.7	5.0	8.3	12.2	0.8	0.8	43.1	1.9	13.8	11.5	0.3	0.4	15.1	0.5	1.2	14.8	4.1	1.0	19.6	2.4	4.4	10.5	3.1	0.6	0.7	18.6	0.8	0.8	3.9	12.6	4.0	9.3	6.8	0.9	1.2	1.2	17.9	0.1	0.0	1.9	0.0	0.0	0.0	2.2	0.8	0.1	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.7	4.0	0.2	5.5	0.5	5.6	0.0	0.0	0.0	1.5	0.1	3.1	0.3	0.1	40.4	0.0	0.1	0.0	0.0	0.5	0.4	0.3	0.0	37.0	0.0	0.0	0.0	0.0	0.0	2.1	0.7	2.1	0.1	1.9	0.5	0.0	4.8	0.0	1.0	0.0	0.0	17.6	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	10.5	6.0	7.3	8.3	12.2	13.8	11.5	14.8	18.6	12.6	17.9	1.7	240.4	12.6	0.0	0.0	0.0	4.7	0.0	13.1	20.5	6.2	3.4	6.2	0.0	19.8	0.0	4.2	0.1	0.0	0.0	0.0	0.9	0.2	0.4	1.5	1.6	0.0	0.0	0.0	0.0	0.3	10.9	0.0	0.1	1.3	2.2	6.1	0.0	5.1	0.0	0.0	0.0	0.0	2.9	0.0	0.3	0.6	3.0	0.0	0.0	0.2	17.8	0.0	0.0	0.0	1.5	0.1	1.2	0.0	3.1	0.0	0.2	3.6	1.6	0.0	8.7	3.3	0.6	1.6	1.5	0.0	0.1	0.3	0.8	0.4	1.1
ARHGAP15	BM046	ENSG00000075884	"Rho GTPase activating protein 15"	Q53QZ3	2	143091362-143768352	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"bone marrow: 79.8;lymphoid tissue: 75.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 126.3;Early spermatids: 132.3;granulocytes: 88.5;Microglial cells: 250.1;NK-cells: 89.6;T-cells: 149.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 59.4;HEL: 75.8;HL-60: 124.3;MOLT-4: 82.0;NB-4: 100.4;THP-1: 131.0;U-698: 89.5;U-937: 63.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032125			Uncertain	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA		38000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA032125: AB_10671370"	"unprognostic (1.59e-2)"	"unprognostic (2.40e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.99e-1)"	"unprognostic (6.62e-3)"	"unprognostic (6.14e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.95e-5)"	"unprognostic (4.40e-2)"	"unprognostic (2.12e-2)"	"unprognostic (4.58e-2)"	"unprognostic (6.94e-2)"	6.9	5.9	1.4	27.1	1.3	79.8	7.6	2.3	2.3	4.1	1.9	7.3	6.8	2.6	9.7	4.0	2.8	11.4	5.6	1.2	2.2	4.4	10.2	9.8	59.3	3.0	1.9	1.8	1.3	1.7	1.0	4.0	2.7	4.3	7.7	1.3	4.2	5.1	1.2	2.0	15.1	3.9	1.9	44.9	7.5	7.4	2.1	75.2	4.5	2.2	46.3	11.4	4.3	4.0	0.3	0.1	4.9	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.1	59.4	0.2	0.1	0.1	0.1	0.2	0.1	0.3	14.6	0.0	75.8	0.5	0.1	0.0	124.3	1.2	0.0	0.0	0.2	0.2	0.1	0.0	47.0	0.3	4.4	0.0	0.1	82.0	100.4	0.3	0.0	0.1	44.7	0.6	22.7	0.0	0.1	0.2	0.4	0.3	0.2	1.0	0.1	4.5	131.0	0.6	0.4	1.2	0.1	0.2	1.0	0.3	89.5	0.7	63.9	3.9	181.8	32.0	140.1	97.7	34.3	161.6	94.3	172.8	125.7	56.3	86.2	119.0	101.7	207.2	121.4	40.5	54.3	147.7	99.9	1.4	1.3	2.3	2.3	1.2	2.2	3.0	1.9	2.7	1.9	2.1	4.0	8.2	0.0	9.6	2.0	126.3	5.6	0.1	0.0	0.0	0.3	1.8	2.0	3.9	1.5	2.5	0.0	0.0	0.2	78.9	0.3	0.0	0.1	132.3	1.8	2.3	4.3	0.0	26.3	12.2	0.0	0.3	9.7	8.6	3.5	88.5	0.0	8.6	0.8	21.3	1.7	6.8	0.0	0.0	39.9	30.9	17.5	14.9	43.0	8.8	250.1	34.9	0.4	89.6	20.6	3.2	0.0	0.0	3.4	65.8	0.2	0.0	0.7	2.2	0.3	46.0	2.7	31.6	68.4	1.2	0.4	4.5	0.3	149.2	0.1	0.2	0.2
ARHGDIG	RHOGDI-3	ENSG00000242173	"Rho GDP dissociation inhibitor gamma"	Q99819	16	280450-283010	"Predicted intracellular proteins"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 249.4;pancreas: 112.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 12.1;Excitatory neurons: 27.8;Inhibitory neurons: 32.1;Proximal enterocytes: 64.0"	"Cancer enhanced"	"Detected in many"		"glioma: 3.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 7.6;HEK 293: 26.6;MCF7: 34.9;SCLC-21H: 10.9;SH-SY5Y: 13.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078260			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"		"HPA078260: AB_2732375"	"unprognostic (1.11e-2)"	"unprognostic (5.69e-2)"	"unprognostic (7.98e-2)"	"unprognostic (2.66e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.94e-1)"	"unprognostic (5.86e-6)"	"unprognostic (2.81e-2)"	"unprognostic (4.34e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.32e-2)"	4.5	2.8	116.5	1.1	138.7	0.2	1.3	118.2	249.4	0.5	49.9	5.9	16.7	0.1	0.9	0.5	0.5	0.1	10.2	130.1	121.2	0.3	0.2	0.5	0.0	110.3	106.1	0.3	112.7	0.6	10.1	2.2	109.8	0.9	0.4	4.0	0.4	0.3	1.9	0.2	6.9	0.6	84.9	0.1	26.8	3.6	112.6	0.0	0.3	1.4	0.4	0.4	1.1	134.9	0.0	0.8	0.2	2.9	0.0	0.4	0.0	0.1	0.0	0.4	0.0	0.4	0.1	0.0	0.9	0.1	0.0	0.1	7.6	0.0	0.0	0.0	26.6	0.0	0.4	0.2	0.7	0.0	0.1	0.2	0.0	0.0	0.0	1.3	0.3	0.0	1.8	0.1	0.0	34.9	0.0	0.0	3.1	1.6	0.0	0.0	0.0	0.3	0.0	0.0	10.9	13.9	0.2	0.1	0.0	0.4	2.6	0.0	0.3	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	116.5	138.7	118.2	249.4	130.1	121.2	110.3	106.1	109.8	84.9	112.6	134.9	0.1	0.0	0.0	12.1	0.0	0.4	0.0	0.0	0.0	4.0	0.0	0.3	1.4	0.0	0.0	0.0	2.1	0.1	0.0	0.7	0.0	0.2	0.4	0.0	0.4	0.1	1.2	2.7	27.8	11.7	0.2	2.5	6.1	0.0	0.0	0.2	1.4	0.0	0.4	0.0	32.1	3.7	0.0	0.0	0.0	0.6	0.3	0.0	0.0	8.4	0.0	2.2	0.0	6.6	10.9	3.9	3.9	0.0	0.0	0.1	64.0	0.1	0.0	3.7	0.0	0.0	0.4	0.2	3.9	0.0	0.0	0.4	0.0	0.0	7.0	0.1
ARHGEF6	"alpha-PIX, alphaPIX, αPix, Cool-2, Cool2, KIAA0006, MRX46"	ENSG00000129675	"Rac/Cdc42 guanine nucleotide exchange factor 6"	Q15052	X	136665547-136780932	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 193.9;Granulosa cells: 128.2;Microglial cells: 77.8"	"Cancer enhanced"	"Detected in all"		"glioma: 24.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 117.6;HL-60: 153.7;HMC-1: 532.0;JURKAT: 152.7;U-937: 158.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003578	Approved		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"HPA003578: AB_1078203"	"unprognostic (9.64e-2)"	"unprognostic (3.47e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.29e-2)"	"unprognostic (7.28e-2)"	"unprognostic (2.06e-3)"	"unprognostic (9.08e-2)"	"unprognostic (7.87e-3)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.69e-3)"	"unprognostic (5.29e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-3)"	44.0	16.2	23.4	30.5	24.4	31.4	23.5	25.0	19.5	10.7	11.6	13.2	7.5	12.9	5.3	7.6	7.0	17.3	32.9	25.2	26.9	6.7	8.5	25.6	41.8	26.8	29.2	16.5	3.9	10.3	6.2	46.9	27.8	7.8	11.1	4.6	8.7	8.8	68.7	6.2	14.4	16.6	29.0	39.4	12.3	3.8	26.5	51.4	5.6	54.7	39.6	14.3	8.7	30.1	1.1	0.0	5.1	0.0	11.2	28.5	0.1	1.6	9.5	1.5	8.2	0.0	0.0	5.5	2.3	8.0	7.8	0.8	6.1	0.0	1.5	28.1	2.0	117.6	0.1	0.0	4.2	153.7	532.0	30.9	0.1	5.4	0.1	10.1	3.0	152.7	0.5	22.1	20.4	0.2	70.6	88.4	4.9	0.0	2.3	26.6	37.2	0.1	1.6	29.5	0.3	6.7	0.2	1.2	4.0	2.6	3.5	61.2	0.5	7.6	1.2	9.3	7.2	3.6	0.1	57.3	35.1	158.2	10.1	57.2	16.4	71.3	13.8	18.9	16.0	6.2	15.4	11.3	19.1	5.4	13.7	12.3	9.1	12.4	16.1	6.0	21.5	15.3	23.4	24.4	25.0	19.5	25.2	26.9	26.8	29.2	27.8	29.0	26.5	30.1	18.1	6.4	8.9	57.1	22.4	1.1	0.9	0.8	1.2	0.8	16.1	10.8	60.0	0.0	2.4	1.8	0.0	0.3	23.6	0.1	1.9	0.6	12.0	0.9	2.4	13.2	0.0	11.3	20.6	1.8	0.4	10.7	5.6	1.6	193.9	128.2	12.5	2.5	15.2	13.5	21.6	0.4	0.0	46.5	25.1	35.8	14.9	40.3	3.6	77.8	36.1	4.7	36.0	48.2	4.3	0.7	0.0	14.7	12.8	0.4	0.0	0.2	2.2	0.3	13.1	33.5	18.5	0.7	0.7	0.6	1.7	0.4	40.5	30.1	0.1	0.7
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2 apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 271.6;Inhibitory neurons: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"B-cells: 5.4;T-cells: 8.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 44.2;HL-60: 43.7;Karpas-707: 72.9;U-266/70: 217.4"	"Low region specificity"	"Detected in all"							"CAB000003, HPA055295"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane"	Nucleoplasm	"CAB000003: AB_2064429, HPA055295: AB_2682776"	"unprognostic (1.11e-3)"	"prognostic favorable (5.13e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.51e-2)"	"prognostic favorable (1.29e-8)"	"unprognostic (6.67e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (2.63e-1)"	12.8	1.9	5.5	10.2	7.8	5.0	9.6	4.7	3.4	10.7	0.0	6.2	4.4	11.6	2.9	5.9	11.8	6.5	5.3	2.9	6.6	6.7	2.1	3.7	14.7	11.2	7.9	14.5	3.1	13.0	4.7	4.6	7.5	6.4	5.5	2.1	3.7	7.0	16.5	4.8	8.1	6.6	7.9	17.9	3.8	1.5	8.2	18.3	24.0	8.8	14.6	5.4	7.7	5.7	1.7	0.3	6.8	5.9	6.7	1.3	2.4	1.0	0.7	2.4	2.0	3.5	0.4	0.3	1.1	0.9	4.7	0.4	6.7	0.9	1.5	44.2	1.6	0.5	2.0	0.7	2.0	43.7	5.6	1.7	0.8	3.3	5.8	1.1	0.7	4.3	0.8	72.9	2.2	1.4	9.8	10.7	1.5	0.8	1.3	39.5	1.9	26.5	7.4	8.5	7.2	6.4	0.3	0.3	8.5	1.4	0.3	29.9	0.3	9.9	3.3	0.9	5.1	217.4	40.1	2.9	1.9	24.9	6.0	0.3	0.0	0.0	1.9	0.0	7.6	5.4	6.3	3.4	0.1	3.1	3.3	3.2	0.0	0.2	0.3	0.2	8.5	1.3	5.5	7.8	4.7	3.4	2.9	6.6	11.2	7.9	7.5	7.9	8.2	5.7	7.1	0.0	1.1	271.6	84.9	19.5	33.6	1.6	13.6	1.9	39.7	19.7	17.4	18.6	2.4	7.3	0.0	14.0	39.9	2.7	15.6	3.7	0.4	9.8	9.8	5.9	5.4	3.8	60.7	0.0	0.7	15.8	5.6	24.9	15.8	38.8	3.9	1.2	9.4	0.0	102.3	10.5	24.4	15.0	29.6	1.9	8.7	29.0	46.2	88.1	19.7	18.8	18.6	76.4	56.7	0.2	5.9	13.9	50.1	41.6	0.9	18.0	0.1	0.6	26.3	48.8	19.7	0.3	1.3	6.2	17.6	49.1	76.1	24.1	9.8	76.2
CADM3	"BIgR, FLJ10698, IGSF4B, Necl-1, NECL1, SynCAM3, TSLL1"	ENSG00000162706	"Cell adhesion molecule 3"	Q8N126	1	159171609-159203313	"Predicted intracellular proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 151.6;placenta: 80.6"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 146.4;Excitatory neurons: 35.5;Fibroblasts: 39.5;Horizontal cells: 35.3;Inhibitory neurons: 40.5;Muller glia cells: 39.4"	"Cancer enriched"	"Detected in many"	4	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 65.0;HSkMC: 218.8;hTERT-HME1: 118.5;WM-115: 60.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002981, CAB025746"	Enhanced	Supported			"Intracellular and membrane"	NA	NA		800000		"Cluster 6: Brain - Smell perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"			"CAB025746: , HPA002981: AB_1078916"	"unprognostic (1.74e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.33e-2)"	"unprognostic (9.32e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (6.12e-3)"	"prognostic unfavorable (1.03e-5)"	"unprognostic (5.52e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (5.75e-4)"	17.3	7.9	102.0	15.1	139.6	0.1	9.2	151.6	145.4	27.6	1.2	28.2	4.4	3.9	1.3	11.5	9.2	6.2	18.1	143.1	96.2	2.2	0.6	5.0	14.3	87.4	84.1	1.5	2.2	0.2	31.0	80.6	120.7	5.1	14.4	66.8	5.9	4.7	2.3	13.0	15.8	6.1	66.3	13.3	11.1	3.0	99.4	1.2	7.3	6.5	9.8	16.2	31.0	60.8	0.0	0.0	0.6	0.0	4.2	1.2	0.0	0.0	0.0	9.4	1.8	0.0	0.0	0.1	0.5	0.0	0.1	0.1	0.0	0.0	3.8	0.0	0.0	3.7	0.0	0.0	65.0	0.0	0.2	218.8	0.0	0.1	118.5	0.0	5.3	0.0	0.0	0.2	2.1	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.1	4.1	0.0	0.0	5.0	0.0	0.1	9.1	0.0	32.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	60.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.0	139.6	151.6	145.4	143.1	96.2	87.4	84.1	120.7	66.3	99.4	60.8	4.2	0.0	0.5	11.4	0.0	6.6	0.1	0.0	0.6	146.4	0.1	0.8	0.6	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.0	0.0	0.2	8.0	0.0	0.0	35.5	0.0	0.8	39.5	0.5	0.0	0.0	0.0	3.6	0.0	1.2	35.3	40.5	0.0	0.0	0.0	10.7	8.3	0.6	0.3	24.9	1.9	0.0	39.4	0.0	18.6	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	9.6	0.0	16.3	3.6	3.1	2.6	0.3	4.3	0.7	0.6	0.0	0.0	0.1
CAMK2A	"CAMKA, CaMKIIα, CaMKIINalpha, KIAA0968"	ENSG00000070808	"Calcium/calmodulin dependent protein kinase II alpha"	Q9UQM7	5	150219491-150290291	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins"		"Calmodulin-binding, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 662.9"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 245.8"	"Cancer enriched"	"Detected in single"	13	"glioma: 6.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 662.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;SCLC-21H: 3.0;SuSa: 1.4;U-87 MG: 3.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 1071.1"	"CAB004330, HPA051783, HPA051785, HPA053973"	Supported		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		66000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Cell Junctions, Cytosol"	"CAB004330: AB_626788, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (7.20e-3)"	"unprognostic (6.47e-3)"	"unprognostic (6.16e-3)"	"unprognostic (4.85e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.19e-3)"	"unprognostic (3.07e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.49e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.00e-8)"	"unprognostic (2.71e-4)"	"unprognostic (1.68e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.36e-3)"	0.2	0.9	161.7	0.2	230.9	0.1	0.1	0.0	662.9	1.2	0.0	1.0	0.1	2.8	0.3	1.3	1.5	0.3	4.8	453.1	0.0	0.7	0.2	0.9	0.0	0.0	0.0	0.4	0.1	0.0	3.5	0.3	0.0	0.8	0.2	1.9	0.7	0.4	95.0	0.7	0.4	2.4	0.0	0.3	0.5	0.1	0.0	0.0	0.1	34.7	0.0	2.0	0.7	99.6	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.8	0.5	0.3	0.0	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.9	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.0	0.0	0.1	0.0	0.1	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	161.7	230.9	0.0	662.9	453.1	0.0	0.0	0.0	0.0	0.0	0.0	99.6	0.0	0.0	0.0	12.1	0.0	3.4	0.0	0.0	0.0	5.1	0.0	0.0	14.9	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.2	0.2	0.0	0.0	245.8	0.0	0.1	2.2	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.0	55.5	0.0	0.0	0.0	0.8	0.3	0.0	0.0	3.6	9.4	0.0	0.4	0.0	8.5	8.1	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.1	0.0	3.6	1.8	0.0	0.3	0.0	1.4	0.3	0.2	0.0	0.0	0.0
CORO2B	"ClipinC, KIAA0925"	ENSG00000103647	"Coronin 2B"	Q9UQ03	15	68578993-68727806	"Plasma proteins, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.4;retina: 45.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 57.1;Bipolar cells: 43.2;Cone photoreceptor cells: 37.5;Excitatory neurons: 96.6;Inhibitory neurons: 50.0;Oligodendrocytes: 146.4"	"Group enriched"	"Detected in many"	8	"glioma: 34.7;melanoma: 21.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.2"	"Lineage enriched"	"Detected in single"	13	"B-cells: 1.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.8;ASC TERT1: 57.5;HSkMC: 41.6;hTEC/SVTERT24-B: 34.6;U-87 MG: 59.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017960	Enhanced	Supported	Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Focal adhesion sites"		"HPA017960: AB_1847167"	"unprognostic (1.35e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.81e-3)"	"unprognostic (4.71e-3)"	"unprognostic (3.28e-1)"	"unprognostic (8.11e-5)"	"unprognostic (4.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.12e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.87e-2)"	10.9	3.5	44.1	2.0	60.9	0.7	7.2	62.1	66.5	7.2	28.2	5.9	1.2	7.5	2.2	1.4	27.5	4.7	16.4	48.1	43.5	9.2	1.3	5.1	1.8	62.4	62.7	14.9	2.2	0.5	3.5	3.2	58.0	4.3	1.5	45.2	2.7	4.9	2.6	4.1	2.8	6.3	51.9	3.9	3.1	1.0	66.5	1.3	6.1	4.5	0.8	4.1	3.7	83.4	0.6	0.8	26.2	2.2	26.8	57.5	0.0	13.7	15.0	2.3	3.2	0.3	3.0	3.5	1.6	2.3	3.7	0.2	1.0	0.3	9.5	0.0	1.2	0.0	0.0	1.2	9.8	0.0	0.4	41.6	0.3	34.6	2.0	20.4	1.0	0.0	0.0	0.1	24.4	0.1	0.0	0.1	6.5	0.0	0.1	2.2	0.1	1.2	3.7	0.0	15.3	0.3	0.2	0.0	7.8	4.8	0.0	3.1	0.2	7.8	8.9	1.7	18.3	0.0	0.0	3.5	59.2	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.1	60.9	62.1	66.5	48.1	43.5	62.4	62.7	58.0	51.9	66.5	83.4	2.8	0.0	0.0	57.1	1.1	1.0	0.4	0.0	0.0	43.2	0.1	1.0	1.5	0.0	0.0	7.3	37.5	0.0	0.0	0.0	0.0	3.8	0.4	2.1	11.6	3.0	3.6	0.0	96.6	0.6	0.0	8.0	0.0	0.3	0.0	0.9	6.4	0.0	0.2	0.0	50.0	0.3	0.0	0.3	0.7	0.7	7.8	0.3	7.2	11.2	0.1	12.5	0.0	17.1	146.4	0.6	0.0	0.4	0.0	0.1	0.0	0.1	8.1	21.4	6.6	1.4	2.1	0.2	0.5	0.1	0.9	0.0	0.1	7.5	0.0	0.1
CRISPLD1	"Cocoacrisp, DKFZp762F133, LCRISP1"	ENSG00000121005	"Cysteine rich secretory protein LCCL domain containing 1"	Q9H336	8	74984505-75034558	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 29.4"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 36.1;Endometrial ciliated cells: 62.2;Oligodendrocyte precursor cells: 81.4"	"Cancer enhanced"	"Detected in many"		"glioma: 30.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 134.4;SH-SY5Y: 72.0;SuSa: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA024725	Uncertain				"Secreted - unknown location"	NA	NA		8200	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA024725: AB_1847238"	"unprognostic (2.16e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.01e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.39e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.23e-1)"	2.7	1.3	3.9	2.5	4.0	1.5	29.4	3.4	3.1	6.3	3.4	2.7	0.7	8.6	4.9	5.0	7.4	10.0	8.8	4.3	8.0	2.1	2.1	2.3	2.8	5.8	10.4	5.7	2.4	19.3	1.2	7.8	8.3	24.6	1.6	3.1	19.3	2.6	0.5	2.3	1.2	7.0	6.3	2.0	0.9	3.8	4.1	9.4	15.1	1.2	1.1	2.5	1.1	10.7	0.0	1.7	134.4	0.0	0.0	0.0	4.5	0.0	0.0	1.6	1.9	0.8	0.0	0.0	19.0	0.0	2.2	0.1	11.3	0.1	0.0	0.1	5.2	0.2	5.1	0.0	3.0	0.0	1.0	7.2	0.3	0.1	1.0	16.6	0.0	1.0	0.0	0.0	0.0	0.1	0.9	0.2	13.9	0.0	5.0	0.0	18.5	0.2	0.0	0.0	0.8	72.0	0.0	0.1	8.0	27.5	10.4	6.4	0.0	3.8	19.6	0.2	0.5	2.4	0.9	0.0	4.6	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.9	4.0	3.4	3.1	4.3	8.0	5.8	10.4	8.3	6.3	4.1	10.7	1.0	3.2	0.0	12.7	0.0	0.8	6.1	1.4	17.6	1.6	10.3	36.1	0.4	0.0	5.4	1.8	0.0	22.7	0.3	0.0	0.0	0.0	15.3	62.2	4.9	3.2	0.0	3.0	15.7	0.0	3.8	9.2	0.0	22.4	3.8	1.8	23.6	0.1	2.0	0.0	11.1	0.0	0.0	0.9	0.0	1.5	4.1	0.4	7.2	1.9	0.0	8.8	0.0	81.4	0.9	0.0	0.0	1.5	0.0	9.4	0.0	0.2	22.5	0.9	0.0	0.4	1.5	1.3	6.0	2.5	1.0	12.0	0.4	6.3	0.0	2.3
CRTAC1	"ASPIC1, CEP-68, FLJ10320"	ENSG00000095713	"Cartilage acidic protein 1"	Q9NQ79	10	97865000-98030828	"Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 45.6;fallopian tube: 38.2;lung: 50.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 119.5;Club cells: 36.4;Inhibitory neurons: 63.6;Oligodendrocyte precursor cells: 54.8"	"Cancer enhanced"	"Detected in many"		"melanoma: 43.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 3.0;HMC-1: 2.5;HUVEC TERT2: 7.1;SCLC-21H: 4.7;SK-MEL-30: 7.7;TIME: 9.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008175	Enhanced				"Secreted to extracellular matrix"	NA	NA		550000000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"			"HPA008175: AB_1847254"	"unprognostic (2.55e-1)"	"unprognostic (6.41e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (5.01e-6)"	"unprognostic (2.54e-1)"	"unprognostic (6.96e-3)"	"unprognostic (9.30e-2)"	"unprognostic (9.13e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.01e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.69e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (6.70e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.29e-3)"	"prognostic favorable (1.51e-4)"	4.4	0.8	8.7	1.1	23.7	0.0	2.4	10.9	20.1	6.4	0.9	11.5	0.5	1.3	3.8	8.3	38.2	0.3	10.6	9.1	8.1	4.3	0.4	50.0	0.4	45.1	10.2	0.7	1.3	0.8	5.3	0.0	45.6	2.3	0.4	11.3	3.4	33.6	1.1	4.1	2.3	0.8	12.6	0.1	1.8	3.9	18.5	0.2	4.7	1.5	0.3	30.2	4.9	15.5	0.0	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.1	0.0	0.0	0.0	0.2	0.7	0.0	3.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	4.7	1.1	0.5	0.0	7.7	0.3	0.0	0.0	9.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	23.7	10.9	20.1	9.1	8.1	45.1	10.2	45.6	12.6	18.5	15.5	1.9	22.4	119.5	2.9	0.0	1.5	2.7	1.3	5.7	10.1	2.6	2.8	7.1	1.5	36.4	9.2	0.0	0.0	0.1	0.0	0.0	4.6	0.1	0.5	0.1	8.8	1.8	0.0	22.9	0.7	0.0	2.3	0.0	0.6	5.1	0.0	5.7	0.1	0.0	0.0	63.6	0.0	0.0	0.6	0.9	0.6	0.0	0.2	8.8	2.8	0.0	14.1	0.0	54.8	6.2	0.6	0.0	0.4	1.2	1.3	0.0	0.0	0.9	5.3	0.0	3.5	0.3	1.5	1.9	13.1	0.4	0.0	0.4	0.0	0.0	1.7
CSMD2	KIAA1884	ENSG00000121904	"CUB and Sushi multiple domains 2"	Q7Z408	1	33513999-34165842	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 9.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 159.0;Inhibitory neurons: 148.9;Oligodendrocyte precursor cells: 314.7;Oligodendrocytes: 52.5"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 5.6;fHDF/TERT166: 6.8;HEL: 10.5;NTERA-2: 8.1;PC-3: 8.4;U-87 MG: 23.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.33e-2)"	"unprognostic (2.98e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.31e-3)"	"unprognostic (5.90e-2)"	"unprognostic (7.44e-2)"	"unprognostic (5.36e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.25e-5)"	"unprognostic (1.03e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.38e-2)"	0.2	0.5	5.3	0.2	3.2	0.0	0.1	0.7	4.8	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	1.1	0.2	7.1	5.5	0.1	0.0	0.1	0.2	2.3	2.7	0.0	0.2	0.0	0.1	0.0	1.8	0.2	0.1	0.9	0.0	0.2	0.0	0.1	0.1	0.3	1.0	0.2	0.1	0.5	9.3	0.0	0.1	0.1	0.4	0.3	0.0	2.5	0.0	0.0	0.0	0.0	0.2	1.1	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.1	1.4	0.0	2.4	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	3.2	0.7	4.8	7.1	5.5	2.3	2.7	1.8	1.0	9.3	2.5	1.4	6.4	3.0	2.6	0.0	0.3	0.6	0.0	0.0	11.2	0.1	0.0	5.5	0.0	0.0	1.8	2.1	0.0	0.1	0.0	0.0	4.3	3.2	0.2	2.3	1.2	0.0	0.0	159.0	2.9	0.1	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.7	148.9	0.0	0.0	0.0	0.3	6.0	1.5	0.4	0.0	12.2	0.3	0.1	0.0	314.7	52.5	1.4	0.0	3.8	0.0	0.9	0.0	0.1	0.0	1.9	0.0	1.4	0.7	0.3	2.1	0.0	0.4	0.0	0.2	0.2	0.0	0.3
DISC1		ENSG00000162946	"DISC1 scaffold protein"	Q9NRI5	1	231626790-232041272	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Neurogenesis, Wnt signaling pathway"	"Developmental protein"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 21.7"	"Cell type enriched"	"Detected in many"	4	"Rod photoreceptor cells: 113.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"THP-1: 11.4;TIME: 8.7;WM-115: 8.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA048911			Supported	"Intermediate filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Intermediate filaments, Cytosol"		"HPA048911: AB_2732549"	"unprognostic (1.08e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.69e-3)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.89e-2)"	"unprognostic (9.53e-2)"	"unprognostic (1.31e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-1)"	2.4	1.4	5.3	3.1	5.4	2.6	1.9	3.9	5.6	2.1	2.6	1.5	1.1	1.5	0.5	1.3	1.1	2.6	9.0	4.2	4.9	1.1	1.4	1.7	2.4	6.9	5.8	4.4	0.8	1.1	1.0	7.3	6.9	1.2	1.2	21.7	2.0	0.9	1.4	1.2	1.3	1.4	5.6	2.9	1.0	0.9	7.3	3.1	1.8	1.1	1.7	1.6	1.3	7.7	0.0	0.4	4.0	0.1	0.1	0.3	2.8	1.6	3.6	4.1	3.5	1.4	0.8	0.1	4.8	1.3	1.0	0.0	0.3	0.1	3.7	2.6	1.7	2.2	0.3	4.0	0.5	3.7	5.1	2.2	0.7	1.4	1.2	2.8	3.8	2.7	0.0	1.4	4.6	0.4	1.1	5.6	2.0	0.0	1.5	2.7	1.1	0.4	0.1	0.0	0.7	2.2	1.4	0.0	2.4	1.0	0.0	11.4	8.7	2.1	2.3	1.0	0.9	0.9	0.7	0.0	1.7	5.6	8.8	0.1	0.8	0.0	0.2	0.8	0.1	0.0	0.4	0.0	1.0	0.1	0.4	0.1	0.7	0.2	0.4	0.6	0.1	0.2	5.3	5.4	3.9	5.6	4.2	4.9	6.9	5.8	6.9	5.6	7.3	7.7	6.7	0.0	1.1	0.0	2.1	0.9	0.5	0.7	3.4	23.3	2.0	1.8	7.2	0.0	1.2	3.7	8.4	8.0	2.0	0.5	0.0	0.6	16.6	3.4	2.1	6.7	0.0	2.1	0.0	1.1	0.8	3.0	0.0	4.5	7.0	8.0	10.0	0.0	11.3	0.0	0.0	0.1	0.0	13.0	12.6	23.2	0.9	13.7	3.6	0.0	5.6	2.4	2.1	0.0	0.0	2.0	0.3	1.5	2.1	0.7	0.0	0.2	2.5	113.1	0.0	4.6	2.7	1.4	1.6	0.5	1.1	2.5	5.8	8.1	0.7	0.6
DUOXA1	"FLJ32334, mol, NIP, NUMBIP"	ENSG00000140254	"Dual oxidase maturation factor 1"	Q1HG43	15	45117367-45129938	"Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 189.0;skin 1: 91.6;thyroid gland: 111.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 60.9;Alveolar cells type 2: 118.0;Club cells: 35.5;Glandular and luminal cells: 47.7;Respiratory ciliated cells: 36.9;Squamous epithelial cells: 53.6;Urothelial cells: 44.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 30.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HaCaT: 103.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA041578	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 11: Alveolar cells - Smell perception"			"HPA041578: AB_10795691"	"unprognostic (1.28e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (2.71e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.45e-2)"	"unprognostic (6.69e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.17e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.36e-2)"	1.1	5.0	0.2	1.3	0.5	0.1	4.0	0.7	1.1	32.1	0.0	0.9	0.8	4.6	49.3	189.0	5.7	4.3	2.1	0.5	0.3	0.8	0.3	64.3	0.1	0.6	0.1	1.1	0.4	5.0	0.7	0.8	0.8	21.6	0.5	0.1	27.5	12.0	0.5	91.6	0.8	0.2	0.1	0.1	43.6	0.2	0.7	0.7	111.1	0.0	17.9	23.3	77.4	2.9	10.6	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	103.9	0.0	0.2	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	14.5	0.0	0.3	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.7	1.1	0.5	0.3	0.6	0.1	0.8	0.1	0.7	2.9	0.0	60.9	118.0	1.0	0.0	9.4	18.8	26.9	18.2	0.6	1.4	1.7	0.5	0.0	35.5	0.0	2.1	2.4	0.0	3.3	0.0	2.0	0.1	28.7	4.0	0.8	3.0	0.0	0.7	3.1	0.1	1.6	8.6	47.7	1.3	0.3	0.0	0.0	0.3	0.0	0.4	0.1	4.1	0.0	1.2	0.0	0.3	0.8	0.0	0.0	0.6	0.1	0.0	0.5	1.8	1.9	3.3	0.0	0.0	13.4	0.0	0.0	36.9	0.1	0.0	0.7	1.1	0.0	0.9	53.6	21.9	3.0	0.6	0.1	0.4	44.2
FMNL3	"DKFZp762B245, MGC45819, WBP3"	ENSG00000161791	"Formin like 3"	Q8IVF7	12	49636499-49708165	"Predicted intracellular proteins"	Angiogenesis	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 35.8;Cone photoreceptor cells: 39.6;dendritic cells: 48.6;Microglial cells: 119.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 5.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"TIME: 47.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002552, HPA023201"	Uncertain		Supported	"Golgi apparatus,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles, Plasma membrane"	Cytosol	"HPA002552: AB_1078862, HPA023201: AB_1848575"	"unprognostic (2.97e-1)"	"unprognostic (2.77e-3)"	"unprognostic (4.97e-3)"	"unprognostic (7.19e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.33e-3)"	"unprognostic (5.37e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.67e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (3.58e-5)"	"unprognostic (1.04e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.69e-2)"	12.2	5.7	13.7	20.5	13.2	5.2	10.6	13.0	11.2	9.6	3.0	8.0	5.7	11.2	19.2	4.5	6.9	11.1	12.6	11.0	12.6	9.3	2.7	17.4	23.5	21.7	14.6	16.1	3.2	3.6	4.1	14.0	18.2	6.0	5.6	2.7	4.6	4.4	5.6	4.4	10.2	11.5	17.7	13.4	6.6	10.1	20.4	20.1	13.4	6.7	28.3	8.6	6.3	20.4	8.6	2.5	18.4	6.1	5.0	20.1	0.2	10.4	21.0	13.8	12.1	9.7	2.3	18.2	19.5	12.4	15.2	0.4	9.5	4.3	12.6	16.2	3.6	20.1	2.9	0.5	8.8	4.0	25.1	12.7	0.7	21.7	9.1	41.2	37.1	9.0	4.6	13.0	20.5	6.3	16.6	6.0	6.0	0.9	5.5	7.9	23.0	2.8	13.1	1.3	3.0	8.6	6.0	0.8	11.8	9.3	1.5	5.9	47.2	34.2	11.8	0.6	18.2	6.7	0.4	9.8	21.3	12.4	14.7	3.0	0.1	0.8	0.8	0.4	0.4	0.2	0.3	0.5	0.2	1.1	0.4	0.5	0.0	0.6	0.3	5.1	0.1	0.5	13.7	13.2	13.0	11.2	11.0	12.6	21.7	14.6	18.2	17.7	20.4	20.4	35.8	3.2	3.4	6.8	17.5	1.7	0.7	0.4	2.2	11.3	1.3	2.3	3.3	0.0	1.4	1.8	39.6	2.1	48.6	0.1	0.0	0.3	2.0	0.7	2.6	29.7	0.0	1.7	16.0	0.6	0.8	7.1	1.5	2.0	27.8	5.4	15.7	0.8	11.1	3.3	6.5	0.8	0.0	6.9	9.0	4.6	3.7	17.7	5.4	119.0	22.9	0.5	16.5	27.6	5.5	0.8	0.1	6.4	1.8	0.8	0.0	0.2	0.2	2.0	13.1	15.5	10.3	5.9	7.5	0.4	1.4	2.5	13.6	2.6	0.1	0.4
FRMD3	"EPB41L4O, MGC20553"	ENSG00000172159	"FERM domain containing 3"	A2A2Y4	9	83242990-83538546	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.0;skeletal muscle: 81.2;tongue: 74.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 108.6;Cardiomyocytes: 73.7;Cone photoreceptor cells: 79.2;Early spermatids: 121.9;Horizontal cells: 101.0;Late spermatids: 122.8;Sertoli cells: 72.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 27.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.0;intermediate monocyte: 3.4;neutrophil: 2.5;non-classical monocyte: 1.5"	"Group enriched"	"Detected in many"	7	"granulocytes: 2.5;monocytes: 3.4"	"Cell line enhanced"	"Detected in many"		"HEL: 24.0;OE19: 49.2;RPMI-8226: 79.6;SCLC-21H: 28.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017285	Approved		Approved	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"	"Plasma membrane"	"HPA017285: AB_2669569"	"unprognostic (4.45e-2)"	"unprognostic (1.85e-1)"	"unprognostic (1.93e-1)"	"unprognostic (6.44e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (3.93e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.87e-2)"	"prognostic favorable (7.24e-4)"	"unprognostic (3.12e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (1.79e-4)"	"unprognostic (1.68e-3)"	9.4	7.3	6.6	2.0	5.5	5.4	6.7	4.3	6.8	3.0	12.0	5.5	2.9	2.7	15.7	2.5	2.2	2.5	85.0	6.3	7.7	14.9	0.7	4.0	1.3	10.1	8.5	1.4	1.6	20.6	4.2	14.8	7.3	2.8	6.6	21.6	2.9	7.8	81.2	2.1	6.7	3.5	7.6	7.2	2.8	9.9	9.9	1.1	7.1	74.7	0.5	4.6	2.6	5.4	0.0	4.3	3.8	0.3	0.7	0.2	0.3	4.1	0.3	0.1	0.0	0.5	5.2	0.9	4.7	1.9	0.9	0.2	0.2	0.0	0.0	0.2	0.2	24.0	4.8	2.8	0.2	0.0	0.3	1.0	0.1	0.0	0.2	0.2	2.7	0.1	0.1	0.1	4.9	0.7	0.0	0.1	0.4	49.2	7.2	0.1	3.0	79.6	6.2	10.1	28.4	13.8	1.4	0.3	0.9	0.6	1.7	0.8	4.4	0.2	0.6	0.1	2.9	0.4	0.3	0.0	0.9	7.6	2.8	0.0	2.0	0.0	0.2	3.4	0.4	0.3	0.1	0.0	0.2	0.4	0.0	0.0	2.5	0.3	1.5	0.4	0.0	6.0	6.6	5.5	4.3	6.8	6.3	7.7	10.1	8.5	7.3	7.6	9.9	5.4	38.4	22.4	1.1	6.2	0.4	1.0	1.0	0.6	0.6	108.6	2.6	1.9	73.7	15.7	1.8	1.8	79.2	0.4	0.2	28.9	17.6	2.8	121.9	2.8	1.4	25.8	1.2	0.8	37.9	2.0	1.2	8.8	2.0	3.9	0.0	0.4	4.2	0.3	0.8	101.0	70.0	38.3	0.0	4.4	0.6	122.8	2.1	8.3	0.0	27.2	4.2	3.9	1.0	10.1	16.0	2.3	10.0	4.9	0.0	1.6	43.6	12.4	3.2	7.0	72.3	66.6	50.7	4.1	1.4	0.2	1.3	0.1	0.9	29.8	2.4	2.3
FRMD4A	"bA295P9.4, FLJ10210, FRMD4, KIAA1294"	ENSG00000151474	"FERM domain containing 4A"	Q9P2Q2	10	13643706-14462142	"Disease related genes, Human disease related genes, Predicted intracellular proteins"			"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 60.8"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 1527.6;Inhibitory neurons: 1622.8;Microglial cells: 1329.4;Oligodendrocyte precursor cells: 442.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 2.3"	"Lineage enriched"	"Detected in single"	5	"B-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 134.0;HUVEC TERT2: 105.8;TIME: 191.6;WM-115: 163.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038449	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Nucleoplasm	"HPA038449: AB_10669539"	"unprognostic (6.77e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.51e-3)"	"unprognostic (5.68e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (2.63e-5)"	"unprognostic (6.21e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.84e-1)"	60.8	5.2	38.9	11.7	28.1	5.4	18.7	0.0	29.2	8.6	0.0	13.1	5.7	5.7	4.0	9.4	8.8	9.6	16.7	24.1	8.5	19.5	12.2	14.2	9.1	15.6	10.9	6.8	15.5	2.4	8.7	22.5	6.2	10.3	6.4	14.1	13.6	10.2	8.1	32.0	7.4	6.5	10.0	32.8	7.9	8.8	14.4	15.6	8.1	7.3	8.4	10.4	8.9	18.9	7.0	7.1	90.1	0.5	12.3	22.0	16.9	40.8	36.5	35.2	48.7	12.1	4.2	0.1	28.3	21.5	48.6	13.5	0.3	3.3	30.7	0.3	9.9	1.4	0.9	0.2	11.0	0.5	1.1	12.8	3.2	134.0	16.4	98.9	105.8	3.1	13.6	0.4	64.7	8.5	4.6	0.8	24.6	0.3	9.6	0.4	30.8	0.2	16.6	5.8	4.3	15.9	0.2	32.7	64.4	16.1	18.5	3.3	191.6	48.8	17.4	47.6	49.3	0.3	0.4	0.3	41.7	1.0	163.4	0.1	0.1	0.0	0.0	0.1	0.1	0.8	0.3	0.1	0.0	2.3	0.3	0.0	0.3	0.2	0.0	0.4	0.4	0.0	38.9	28.1	0.0	29.2	24.1	8.5	15.6	10.9	6.2	10.0	14.4	18.9	48.6	32.1	2.6	168.1	1.7	35.1	13.1	3.0	9.1	54.2	17.1	14.4	11.4	45.8	4.1	33.1	18.8	69.6	0.4	1.1	11.7	15.8	42.5	13.1	5.5	44.0	4.8	81.7	1527.6	4.0	42.1	14.9	4.6	26.9	15.2	58.1	44.3	6.2	35.9	80.8	1622.8	3.4	6.1	95.6	19.9	98.8	2.1	25.5	16.0	1329.4	2.7	46.0	0.0	442.3	61.0	1.8	1.4	1.9	0.9	8.0	0.3	2.7	2.5	12.9	13.1	41.2	45.5	1.3	2.1	20.6	32.7	28.7	3.0	5.3	5.4	4.3
GALNT16	"GalNAc-T16, GALNTL1, KIAA1130"	ENSG00000100626	"Polypeptide N-acetylgalactosaminyltransferase 16"	Q8N428	14	69259277-69357033	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 40.8;heart muscle: 45.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 16.6;Cardiomyocytes: 46.7;Excitatory neurons: 27.6;Fibroblasts: 24.0;Inhibitory neurons: 23.8;Smooth muscle cells: 14.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.5;ASC diff: 11.7;hTEC/SVTERT24-B: 17.0;hTERT-RPE1: 17.2;SCLC-21H: 8.7;U-2 OS: 19.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059136, HPA075325"	Approved		Approved	Vesicles,Cytosol		NA	NA		370000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Vesicles, Cytosol"		"HPA059136: AB_2683919, HPA075325: "	"unprognostic (9.71e-3)"	"unprognostic (7.47e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.30e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.72e-3)"	"unprognostic (3.18e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.62e-4)"	"unprognostic (1.31e-2)"	"prognostic favorable (5.23e-6)"	"unprognostic (5.38e-3)"	"unprognostic (3.34e-2)"	"unprognostic (3.93e-2)"	"unprognostic (7.96e-5)"	14.4	11.6	25.7	2.0	24.4	0.1	12.0	14.7	28.4	7.6	6.5	6.5	2.2	7.3	2.8	3.6	5.6	3.4	45.0	27.0	35.5	7.7	2.0	3.4	3.2	19.6	22.5	2.1	4.3	2.5	4.7	0.4	19.9	4.0	2.2	1.3	23.5	4.6	4.4	7.5	3.7	8.6	16.4	12.1	3.2	3.5	40.8	2.2	4.9	5.8	1.3	3.1	5.0	21.3	0.0	0.8	8.5	0.3	11.7	5.3	0.0	1.3	0.1	1.5	2.3	0.4	0.0	0.0	0.2	1.4	0.8	0.0	3.0	0.0	0.3	0.1	6.0	0.0	0.2	0.5	0.1	0.0	0.5	0.5	0.0	17.0	0.0	17.2	0.9	0.0	0.0	0.0	2.8	0.5	0.0	0.0	1.7	0.0	0.1	0.0	4.8	0.0	0.5	0.0	8.7	3.0	1.8	0.4	0.0	0.3	0.3	0.0	0.1	1.7	19.9	2.2	2.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.7	24.4	14.7	28.4	27.0	35.5	19.6	22.5	19.9	16.4	40.8	21.3	4.0	0.0	0.0	16.6	0.0	4.1	0.4	0.0	0.0	2.8	3.1	3.0	46.7	0.0	0.0	0.0	2.1	0.1	0.2	0.0	3.9	0.1	9.7	0.2	0.4	1.7	0.0	0.0	27.6	0.0	0.0	24.0	0.5	0.2	0.0	0.3	0.0	0.0	0.2	0.0	23.8	0.1	0.0	0.0	6.1	11.2	0.9	0.3	3.6	5.6	0.0	0.1	0.0	8.0	1.6	0.0	0.0	3.8	0.0	0.5	0.1	0.1	0.0	0.8	6.6	10.1	14.8	0.6	2.1	0.3	3.3	0.0	0.3	11.2	0.6	0.4
GASK1B	"C4orf18, DKFZp434L142, ENED, FAM198B, FLJ38155"	ENSG00000164125	"Golgi associated kinase 1B"	Q6UWH4	4	158124474-158173318	"Predicted intracellular proteins, Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 206.2"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 22.9;Cardiomyocytes: 33.8;Endothelial cells: 12.1;Fibroblasts: 14.5;Hofbauer cells: 67.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"classical monocyte: 50.6;intermediate monocyte: 28.8;myeloid DC: 15.1;non-classical monocyte: 14.0"	"Group enriched"	"Detected in many"	41	"dendritic cells: 15.1;monocytes: 50.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 77.0;ASC TERT1: 143.3;HSkMC: 166.4;HUVEC TERT2: 193.3;WM-115: 74.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA007227	Uncertain		Approved	"Nucleoplasm,Nucleoli fibrillar center,Golgi apparatus"		NA	NA		13000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nucleoplasm, Golgi apparatus"	"Nucleoli fibrillar center"	"HPA007227: AB_1847689"	"unprognostic (4.87e-2)"	"unprognostic (7.79e-2)"	"unprognostic (6.60e-3)"	"unprognostic (9.42e-3)"	"unprognostic (2.37e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.13e-2)"	"unprognostic (7.49e-2)"	"unprognostic (9.20e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.25e-3)"	"unprognostic (3.74e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.89e-2)"	73.9	206.2	29.0	39.8	29.2	2.8	47.3	21.8	23.3	47.0	11.9	23.4	13.3	77.7	21.8	17.2	19.4	37.1	77.9	28.7	29.6	9.5	8.6	14.1	11.2	51.7	33.0	140.3	14.2	11.5	2.8	29.0	26.9	23.6	23.3	0.8	23.6	30.0	12.4	7.3	18.5	70.2	34.1	20.8	11.8	10.4	35.5	5.7	17.7	16.7	6.8	43.2	9.2	33.0	12.5	9.9	6.1	1.1	77.0	143.3	11.4	3.1	2.4	0.6	3.7	13.3	4.9	0.1	0.3	5.0	5.1	0.2	70.7	18.9	1.8	0.1	0.2	1.0	0.0	37.0	51.4	0.6	0.3	166.4	4.6	24.2	2.6	8.0	193.3	0.0	13.0	0.0	35.7	0.8	0.0	0.2	0.4	43.4	0.2	0.1	0.5	0.2	0.0	27.5	0.4	0.1	0.0	27.8	8.2	33.4	5.4	0.3	9.3	16.0	17.1	9.6	6.1	0.0	0.1	44.8	2.5	0.3	74.3	0.1	50.6	0.0	0.1	28.8	0.0	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.7	0.1	14.0	0.6	0.0	17.8	29.0	29.2	21.8	23.3	28.7	29.6	51.7	33.0	26.9	34.1	35.5	33.0	22.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	1.2	14.5	0.0	0.0	0.0	0.0	0.0	0.0	67.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0
HS3ST3A1	"30ST3A1, 3OST3A1"	ENSG00000153976	"Heparan sulfate-glucosamine 3-sulfotransferase 3A1"	Q9Y663	17	13494032-13601929	"Enzymes, Metabolic proteins, Predicted intracellular proteins"		Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 8.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.8;Granulosa cells: 11.6;Hepatic stellate cells: 7.1;Horizontal cells: 26.9;Leydig cells: 13.7;Squamous epithelial cells: 9.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"medulla oblongata: 5.9"	"Immune cell enhanced"	"Detected in some"		"T-reg: 2.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 1.7;T-cells: 2.2"	"Group enriched"	"Detected in many"	4	"PC-3: 40.9;U-251 MG: 123.0;U-87 MG: 73.2"	"Region enhanced"	"Detected in many"		"olfactory bulb: 5.0"	"Region enhanced"	"Detected in some"		"olfactory bulb: 5.3"	"HPA062518, HPA071530"	Uncertain		Approved	Microtubules		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 64: Macrophages - Immune response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 40: Granulosa cells - Unknown function"	Microtubules		"HPA062518: AB_2684789, HPA071530: AB_2686411"	"unprognostic (2.88e-3)"	"unprognostic (4.21e-2)"	"unprognostic (8.35e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-3)"	"unprognostic (4.44e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.12e-4)"	"unprognostic (1.12e-2)"	"unprognostic (8.52e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.85e-9)"	"unprognostic (1.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.33e-3)"	"unprognostic (4.70e-3)"	0.4	2.0	0.1	1.9	1.0	1.0	0.4	0.0	0.6	4.5	3.2	1.2	1.4	0.7	0.1	4.6	1.3	0.3	2.5	0.2	0.0	1.4	1.9	1.2	2.6	5.9	1.4	8.1	0.3	0.0	0.7	2.7	1.1	3.1	0.3	1.3	2.0	4.9	0.1	0.7	1.2	0.2	3.5	6.4	0.6	2.3	0.1	0.3	0.3	0.0	1.6	0.5	3.4	0.5	0.1	0.3	3.3	0.0	2.7	6.8	5.1	18.2	4.4	3.2	2.0	0.0	0.6	0.0	2.6	11.2	0.0	0.0	0.1	0.0	3.1	1.1	18.3	4.9	1.5	2.0	1.6	0.0	1.2	4.9	0.1	8.5	2.2	5.5	0.0	0.2	19.2	0.0	3.8	2.5	0.1	3.3	3.5	0.0	40.9	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.1	2.0	0.1	0.6	0.2	3.1	0.4	0.1	123.0	0.0	0.0	0.0	73.2	0.0	9.1	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.4	0.5	0.0	0.0	0.5	0.5	0.2	0.3	0.0	1.7	2.2	0.3	0.1	1.0	0.0	0.6	0.2	0.0	5.9	1.4	1.1	3.5	0.1	0.5	0.2	0.0	0.0	9.8	0.0	0.6	0.0	0.0	5.7	0.3	0.0	0.3	0.8	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.4	0.3	1.1	0.0	0.0	1.8	0.2	0.0	4.7	0.0	0.2	0.0	11.6	7.1	0.0	1.6	26.9	4.1	0.0	0.0	0.8	0.3	0.1	13.7	0.0	0.0	1.9	0.0	2.4	0.0	0.5	0.2	0.7	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	2.8	4.0	0.3	0.4	9.3	0.6	0.1	0.1	0.0	0.0	0.0
IL34	"C16orf77, IL-34, MGC34647"	ENSG00000157368	"Interleukin 34"	Q6ZMJ4	16	70579895-70660682	"Predicted intracellular proteins, Predicted secreted proteins"	"Immunity, Inflammatory response, Innate immunity"	"Cytokine, Growth factor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 106.3;skin 1: 62.0"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 18.3;Peritubular cells: 40.6;Sertoli cells: 19.7;Suprabasal keratinocytes: 20.5;Theca cells: 18.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	13	"eosinophil: 18.5"	"Lineage enriched"	"Detected in single"	185	"granulocytes: 18.5"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1;Hep G2: 2.7;HSkMC: 2.4;NTERA-2: 5.3;U-138 MG: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Secreted to blood"	NA	NA	57100		"Cluster 52: Eosinophils - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.76e-3)"	"prognostic favorable (7.41e-4)"	"unprognostic (5.70e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.27e-2)"	"prognostic favorable (9.69e-4)"	"unprognostic (8.19e-2)"	"unprognostic (1.59e-3)"	"unprognostic (3.83e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (3.52e-8)"	"unprognostic (6.47e-3)"	"unprognostic (4.58e-2)"	"unprognostic (5.83e-2)"	"unprognostic (4.37e-2)"	4.4	22.9	17.1	3.9	18.1	0.1	8.6	8.5	23.3	9.6	23.1	4.0	5.1	2.9	1.0	25.5	3.2	6.7	4.4	22.5	14.5	5.7	2.5	5.0	9.1	13.0	11.7	1.6	1.9	1.0	12.5	0.5	14.1	6.2	2.2	1.2	16.0	3.8	9.6	62.0	6.4	2.5	10.1	106.3	2.4	3.5	19.0	3.9	5.1	2.5	5.0	4.8	13.4	11.6	0.0	0.6	0.1	0.1	0.2	2.1	0.2	0.1	1.8	0.2	0.2	0.4	0.0	0.0	0.3	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	2.7	0.9	0.0	1.6	2.4	0.1	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.5	0.0	0.0	0.0	5.3	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.3	0.0	0.0	0.0	3.6	0.1	0.1	0.1	0.2	0.0	0.0	0.3	0.7	0.1	1.4	0.0	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	18.1	8.5	23.3	22.5	14.5	13.0	11.7	14.1	10.1	19.0	11.6	2.8	0.0	1.8	2.9	0.1	8.3	1.6	3.4	2.2	1.2	15.7	14.7	0.4	1.5	4.9	0.0	4.2	0.1	0.5	0.0	0.0	7.4	0.2	0.5	0.3	6.1	0.0	0.0	12.7	2.0	0.9	9.0	0.0	0.1	0.0	0.0	3.6	0.1	3.8	5.0	11.4	0.1	2.0	0.0	4.2	0.3	18.3	0.4	12.4	5.6	0.0	15.2	0.0	1.5	1.0	0.8	0.1	40.6	0.1	2.4	0.2	0.3	1.2	0.8	19.7	2.0	8.1	0.1	0.4	7.8	20.5	0.8	0.3	18.8	0.5	1.9
ITGB8		ENSG00000105855	"Integrin subunit beta 8"	P26012	7	20330702-20415754	"Cancer-related genes, Predicted membrane proteins"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 53.9;choroid plexus: 39.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 376.2;Glandular and luminal cells: 551.9;Oligodendrocyte precursor cells: 192.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	133	"basophil: 16.5"	"Lineage enriched"	"Detected in single"	133	"granulocytes: 16.5"	"Cell line enhanced"	"Detected in many"		"AF22: 44.3;EFO-21: 54.6;RPTEC TERT1: 88.1;WM-115: 127.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027796, HPA027797"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA027796: AB_10600299, HPA027797: AB_10600879"	"unprognostic (8.32e-3)"	"unprognostic (1.42e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.37e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.75e-2)"	"unprognostic (2.49e-3)"	"unprognostic (8.47e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (2.90e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.63e-2)"	"unprognostic (6.92e-3)"	3.8	2.6	25.7	4.2	41.8	0.3	9.6	53.9	19.2	15.4	39.4	3.7	3.2	7.7	14.0	6.4	7.5	8.7	2.9	19.5	37.5	21.6	0.8	2.4	0.5	38.9	48.4	4.7	13.3	5.1	5.4	5.2	42.7	6.7	2.8	4.6	13.6	9.0	0.2	6.3	4.2	3.0	39.7	0.0	4.2	6.5	35.6	0.8	2.1	0.9	6.9	7.2	9.0	48.6	28.2	1.1	44.3	5.6	3.7	15.2	0.0	0.1	0.5	0.2	1.5	0.3	6.9	0.0	54.6	2.0	1.7	30.1	1.9	4.5	0.5	0.0	0.7	0.0	23.1	0.0	1.8	0.0	0.1	1.8	12.6	0.5	2.4	27.1	2.4	0.0	0.0	8.3	0.8	0.1	0.0	0.0	3.3	0.4	4.8	0.0	3.7	0.0	88.1	2.5	0.7	1.9	8.6	0.2	23.5	0.8	0.7	0.1	3.0	11.2	7.1	3.2	5.8	10.2	0.1	0.0	2.7	0.0	127.0	16.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	25.7	41.8	53.9	19.2	19.5	37.5	38.9	48.4	42.7	39.7	35.6	48.6	0.7	12.8	4.8	106.4	2.5	33.1	117.2	39.4	34.7	13.3	26.3	18.7	3.0	38.6	57.9	38.6	0.0	20.0	0.4	5.0	7.9	26.3	3.0	376.2	150.6	5.2	34.0	0.0	28.1	17.4	1.2	15.5	7.7	551.9	1.3	0.9	1.4	0.2	3.3	1.7	8.2	7.4	34.6	1.0	4.7	6.5	44.1	9.8	3.6	4.7	31.6	24.3	0.0	192.0	119.2	35.8	6.1	44.8	2.0	149.7	14.5	76.7	100.1	1.4	0.0	4.8	7.0	1.4	1.1	34.6	12.4	4.9	5.5	1.9	9.6	150.7
JAM2	"C21orf43, CD322, JAM-B, JAMB, VE-JAM"	ENSG00000154721	"Junctional adhesion molecule 2"	P57087	21	25639258-25717562	"CD markers, Disease related genes, Human disease related genes, Predicted membrane proteins"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 63.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 173.8;Astrocytes: 81.6;Endothelial cells: 148.7;Hepatic stellate cells: 112.8;Microglial cells: 82.4;Oligodendrocyte precursor cells: 76.9"	"Cancer enriched"	"Detected in all"	9	"glioma: 27.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 25.5;BJ hTERT+: 16.5;HDLM-2: 16.7;hTERT-RPE1: 22.5;U-138 MG: 18.1;U-87 MG: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028789, HPA077346"			Supported	"Nucleoplasm,Plasma membrane"		NA	NA		360000	"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	Nucleoplasm	"HPA028789: AB_2732443, HPA077346: AB_2732341"	"unprognostic (1.42e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.53e-2)"	"unprognostic (7.51e-4)"	"unprognostic (2.61e-2)"	"unprognostic (4.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.46e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.86e-2)"	"unprognostic (5.71e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.85e-3)"	20.5	15.8	16.6	3.7	21.5	0.3	16.8	24.0	21.8	16.8	12.8	17.8	6.1	18.5	11.2	7.1	16.1	12.9	19.2	19.2	22.0	9.2	2.2	15.5	3.6	25.9	23.1	16.1	2.8	4.3	8.1	63.5	21.3	9.4	7.9	7.1	6.1	15.4	7.8	5.5	10.7	19.6	26.8	1.6	10.2	17.6	25.2	2.6	10.3	13.2	5.0	11.6	13.2	23.0	0.0	0.0	25.5	0.1	1.0	0.2	0.5	0.8	16.5	2.0	7.6	0.0	0.0	0.1	0.0	0.2	9.7	0.1	2.2	0.0	4.6	16.7	0.7	0.1	0.1	0.1	0.0	0.1	0.1	1.4	0.0	1.8	0.1	22.5	0.0	0.6	0.0	0.2	8.0	0.0	0.4	0.1	8.1	0.2	0.0	3.2	5.3	0.1	0.0	0.0	0.4	3.7	0.2	0.3	0.0	0.3	0.9	0.2	0.0	18.1	1.7	0.1	2.5	1.8	0.1	0.0	13.4	0.1	0.7	0.4	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.6	0.1	0.2	0.4	0.6	0.1	0.4	0.0	0.1	16.6	21.5	24.0	21.8	19.2	22.0	25.9	23.1	21.3	26.8	25.2	23.0	173.8	0.0	2.3	81.6	0.9	7.5	1.4	0.0	2.2	1.4	1.4	9.1	33.2	0.0	0.0	3.7	14.6	0.3	0.5	0.0	0.0	0.2	16.5	1.0	4.7	148.7	0.0	0.0	15.2	0.2	5.3	28.5	0.5	2.1	0.0	4.5	112.8	0.5	1.3	0.0	45.0	0.0	0.0	1.8	10.7	15.6	9.9	2.8	16.0	82.4	0.0	1.8	0.0	76.9	4.1	0.1	0.0	24.5	1.2	1.5	0.0	0.0	0.7	5.2	0.0	5.7	7.0	6.7	4.4	0.8	6.7	0.8	1.6	2.1	0.0	1.2
KIAA1549L	"C11orf41, C11orf69, G2, MGC34830"	ENSG00000110427	"KIAA1549 like"	Q6ZVL6	11	33376108-33674102	"Predicted membrane proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"brain: 26.4;parathyroid gland: 33.5"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 366.9;Inhibitory neurons: 193.5"	"Cancer enhanced"	"Detected in many"		"melanoma: 4.4"	"Group enriched"	"Detected in many"	141	"amygdala: 8.6;basal ganglia: 14.9;cerebral cortex: 26.4;hippocampal formation: 12.3;white matter: 7.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"TIME: 42.4;U-138 MG: 53.8;WM-115: 37.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010132, HPA051594"			Approved	Nucleoplasm,Vesicles		NA	NA		160000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Vesicles	"HPA010132: AB_1078313, HPA051594: "	"unprognostic (3.02e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.34e-5)"	"unprognostic (2.63e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.89e-2)"	"unprognostic (5.27e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.59e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.08e-3)"	"unprognostic (8.46e-2)"	"unprognostic (4.04e-1)"	"unprognostic (1.09e-1)"	0.2	0.4	8.6	0.2	14.9	0.0	0.7	0.0	26.4	0.1	0.0	0.3	0.0	0.1	0.0	0.7	0.0	0.3	0.1	12.3	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.2	0.3	33.5	0.7	1.1	0.0	0.0	0.1	0.9	0.3	0.0	0.1	1.8	0.0	0.1	0.0	0.0	0.1	0.8	0.0	0.1	0.0	0.1	0.7	0.3	0.2	7.9	0.1	1.9	6.1	0.2	1.0	6.5	0.0	24.7	14.4	3.8	2.1	0.0	0.6	18.7	0.3	21.9	19.2	1.4	0.9	7.3	5.7	0.0	3.6	0.0	0.0	0.0	0.1	0.0	0.0	2.6	0.1	6.4	11.0	13.4	16.9	0.5	0.2	20.5	15.1	0.0	0.2	0.0	1.4	0.0	9.1	0.0	1.6	0.0	0.0	9.6	2.2	2.2	0.3	0.0	6.2	0.2	0.0	0.0	42.4	53.8	11.8	1.3	19.6	0.0	0.0	0.0	14.7	0.0	37.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	14.9	0.0	26.4	12.3	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.2	0.0	0.0	18.3	0.1	2.0	0.6	0.6	0.0	5.6	2.2	2.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.8	1.1	0.2	0.1	0.7	0.0	0.0	366.9	0.0	0.2	1.0	0.0	0.6	0.0	0.2	5.0	0.2	0.3	3.3	193.5	0.0	0.0	0.0	0.9	1.2	0.0	0.1	17.8	18.7	0.0	0.1	0.0	40.2	7.2	1.2	0.0	0.4	0.0	1.2	0.0	0.1	0.1	0.4	0.0	0.1	1.8	0.0	1.8	0.6	0.3	0.0	0.0	0.1	0.0	0.7
KLHL3	KIAA1129	ENSG00000146021	"Kelch like family member 3"	Q9UH77	5	137617500-137736089	"Disease related genes, Human disease related genes, Predicted intracellular proteins"	"Ubl conjugation pathway"	Actin-binding	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 44.1;Excitatory neurons: 91.9;Inhibitory neurons: 56.1;Late spermatids: 60.7;Muller glia cells: 46.2;Oligodendrocytes: 66.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 5.8;RT4: 6.1;TIME: 13.5;U-266/70: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051291	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA051291: AB_2681423"	"unprognostic (4.31e-2)"	"unprognostic (5.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.39e-3)"	"unprognostic (3.28e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.71e-1)"	"unprognostic (5.20e-3)"	"unprognostic (1.50e-4)"	4.4	7.1	8.5	2.3	10.6	1.0	3.9	26.7	9.9	5.2	3.4	2.8	1.8	3.3	1.8	2.5	3.7	4.0	16.5	9.5	7.4	8.5	2.5	3.0	3.9	6.8	7.2	5.8	2.4	0.4	8.5	2.3	7.1	3.2	1.6	7.7	2.1	1.5	1.9	2.1	2.9	2.4	5.2	4.2	3.5	6.5	8.3	3.9	9.2	1.6	2.9	3.3	4.7	12.6	0.3	0.3	1.4	0.0	0.8	1.1	0.9	0.3	0.4	0.1	0.2	0.5	5.3	1.3	2.8	0.0	0.0	0.1	0.3	2.5	0.2	1.4	0.6	0.6	1.1	0.0	0.3	0.0	1.0	1.0	0.2	0.6	0.0	2.2	5.8	3.7	0.2	1.1	0.2	0.0	3.0	0.8	2.4	0.0	0.8	2.4	0.0	0.0	0.9	6.1	1.6	0.9	0.3	0.0	0.5	3.8	0.0	0.5	13.5	0.4	0.3	0.0	0.4	7.9	4.7	0.0	5.0	0.1	0.6	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.9	0.3	0.0	0.0	0.9	0.5	0.0	0.7	0.0	0.4	0.4	0.2	8.5	10.6	26.7	9.9	9.5	7.4	6.8	7.2	7.1	5.2	8.3	12.6	13.3	0.0	2.2	20.2	1.9	1.1	1.7	1.4	1.2	15.6	1.8	1.5	36.4	1.5	1.4	7.3	22.9	0.6	5.6	0.5	1.9	0.8	44.1	7.1	1.8	14.1	15.6	2.7	91.9	0.9	0.1	3.9	9.2	7.1	1.3	6.6	24.7	3.7	0.6	5.0	56.1	1.0	0.0	1.3	1.2	60.7	2.5	0.7	1.8	7.5	1.0	46.2	5.2	30.7	66.4	1.3	0.3	1.9	1.0	0.8	0.5	0.3	2.3	6.6	0.0	3.7	3.9	9.2	8.5	1.8	0.9	0.1	3.2	6.8	1.9	1.2
LOXL3		ENSG00000115318	"Lysyl oxidase like 3"	P58215	2	74532258-74555690	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins"	"Inflammatory response"	Oxidoreductase	"Deafness, Stickler syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.0;Hofbauer cells: 17.9;Kupffer cells: 12.5;Macrophages: 12.3;Microglial cells: 30.0;Muller glia cells: 10.6;Oligodendrocyte precursor cells: 11.6;Sertoli cells: 19.7"	"Cancer enhanced"	"Detected in many"		"melanoma: 15.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 11.7;non-classical monocyte: 9.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 143.4;HDLM-2: 110.7;U-138 MG: 245.9;WM-115: 549.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035281	Approved				"Secreted to extracellular matrix"	NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA035281: AB_10601766"	"unprognostic (7.54e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.55e-3)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.68e-3)"	"unprognostic (6.84e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (7.97e-8)"	"unprognostic (1.22e-2)"	"unprognostic (7.33e-3)"	"unprognostic (7.09e-2)"	"unprognostic (3.38e-2)"	6.8	5.3	4.5	7.8	4.7	14.3	3.0	4.5	5.3	5.1	3.8	7.3	4.0	7.4	1.7	3.2	4.9	6.5	8.2	4.5	5.6	2.0	1.5	4.6	4.1	7.0	5.0	2.9	1.1	1.7	2.7	15.9	6.3	3.3	3.7	4.9	1.6	4.0	1.3	2.0	3.9	8.1	5.6	8.9	2.7	2.6	7.0	1.4	2.2	1.5	2.3	5.2	4.0	7.3	1.6	0.3	21.8	3.7	17.1	20.6	4.5	71.0	143.4	33.8	31.8	25.6	1.3	0.1	0.9	73.1	1.6	1.1	2.8	1.8	19.8	110.7	1.0	17.6	1.8	0.2	5.7	0.6	16.7	22.6	0.2	90.6	3.8	12.0	0.7	0.8	0.8	2.8	6.4	4.1	0.2	6.5	12.0	0.8	0.7	2.0	3.1	0.3	0.3	1.2	11.2	12.8	0.6	1.1	14.7	3.2	2.3	1.3	0.3	245.9	8.2	1.4	0.9	1.4	0.5	0.1	92.5	6.8	549.6	0.1	6.0	0.3	0.0	11.7	0.0	0.1	0.1	0.0	3.5	0.1	0.0	0.0	2.5	0.0	9.3	0.4	0.0	2.6	4.5	4.7	4.5	5.3	4.5	5.6	7.0	5.0	6.3	5.6	7.0	7.3	0.9	0.0	0.5	14.0	0.3	0.9	0.2	0.6	0.6	0.9	0.4	0.8	0.3	1.5	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.8	0.0	0.2	4.8	1.2	0.0	0.4	0.4	0.0	1.5	7.1	0.0	0.5	1.3	0.7	0.4	0.1	17.9	1.7	4.2	0.1	0.0	12.5	2.5	0.7	5.0	12.3	0.0	30.0	4.8	10.6	1.0	11.6	0.6	0.3	0.0	4.5	0.1	0.3	0.0	0.1	0.0	0.9	19.7	1.6	5.3	0.6	0.8	0.1	0.1	0.8	0.4	0.2	0.0	0.2
LPAR1	"edg-2, EDG2, Gpcr26, GPR26, LPA1, Mrec1.3, rec.1.3, vzg-1"	ENSG00000198121	"Lysophosphatidic acid receptor 1"	Q92633	9	110873263-111038458	"G-protein coupled receptors, Predicted membrane proteins"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 358.4;choroid plexus: 122.2"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 626.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 9.1;eosinophil: 19.0"	"Group enriched"	"Detected in many"	6	"granulocytes: 19.0;monocytes: 9.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 582.0;ASC TERT1: 337.0;BJ hTERT+: 426.7;HSkMC: 246.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050667			Approved	"Nuclear speckles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nuclear speckles"	"Plasma membrane"	"HPA050667: "	"unprognostic (1.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.79e-2)"	"unprognostic (6.08e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.02e-1)"	"unprognostic (4.29e-3)"	"unprognostic (2.12e-2)"	"unprognostic (5.42e-3)"	"unprognostic (2.78e-2)"	"unprognostic (9.97e-3)"	"unprognostic (1.65e-1)"	30.5	13.3	251.0	18.8	315.0	0.2	25.9	208.8	318.6	57.7	122.2	24.5	13.9	17.0	17.1	15.2	15.8	14.1	24.1	199.5	201.3	9.6	2.6	16.3	17.6	299.6	277.5	12.1	6.6	2.2	5.0	38.8	249.2	21.0	18.3	0.8	16.7	23.6	6.6	20.1	18.3	20.5	224.0	14.8	11.8	6.9	266.2	6.8	16.5	17.5	17.2	27.6	31.7	358.4	11.7	22.2	30.4	0.1	582.0	337.0	0.0	151.6	426.7	104.1	46.8	3.0	1.8	0.0	0.1	157.7	18.6	45.5	0.4	118.5	85.0	0.0	4.1	0.0	1.1	0.0	157.1	0.1	0.2	246.6	6.8	51.4	96.9	62.3	1.8	0.2	0.0	0.2	80.8	0.1	0.0	0.1	5.9	0.0	121.6	0.1	22.4	0.0	23.5	20.6	0.9	7.2	3.1	0.0	0.0	6.2	10.4	0.5	0.1	48.9	1.3	35.3	0.1	1.5	0.0	0.0	7.4	0.0	54.9	1.5	9.1	19.0	0.0	3.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	1.9	2.1	1.3	0.2	0.0	2.1	251.0	315.0	208.8	318.6	199.5	201.3	299.6	277.5	249.2	224.0	266.2	358.4	1.9	0.0	1.1	6.2	0.2	13.0	15.5	8.5	4.0	0.0	3.4	6.0	1.4	1.5	9.1	0.0	0.0	0.5	0.3	6.6	1.9	1.8	1.4	3.6	40.4	1.9	0.0	0.0	1.0	2.9	0.4	61.4	6.1	8.7	0.0	0.0	2.5	0.0	3.3	0.0	15.6	3.7	4.1	4.1	15.1	2.7	38.8	3.6	14.2	141.5	12.0	1.0	1.0	1.0	626.8	2.0	2.9	70.7	0.7	12.7	4.5	0.2	3.0	0.2	0.0	13.3	6.3	0.3	2.4	15.2	9.2	0.8	1.2	0.2	4.2	6.7
MAB21L1	CAGR1	ENSG00000180660	"Mab-21 like 1"	Q13394	13	35473789-35476689	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		"Developmental protein, Nucleotidyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 21.9;retina: 68.7"	"Group enriched"	"Detected in some"	14	"Bipolar cells: 57.7;Cone photoreceptor cells: 50.1;Horizontal cells: 87.5;Muller glia cells: 151.1;Rod photoreceptor cells: 125.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.0"	"Region enhanced"	"Detected in many"		"cerebellum: 21.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 36.6;BJ hTERT+: 29.9;BJ hTERT+ SV40 Large T+: 41.7;HBF TERT88: 44.9;hTERT-RPE1: 86.2;SH-SY5Y: 133.5"	"Group enriched"	"Detected in many"	10	"cerebellum: 40.9;midbrain: 18.6;pons and medulla: 12.4"	"Region enhanced"	"Detected in all"		"cerebellum: 33.0"	"HPA049324, HPA059864"			Approved	Nucleoplasm		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"HPA049324: AB_2680712, HPA059864: AB_2684147"	"unprognostic (4.44e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.79e-3)"	"unprognostic (3.87e-4)"	"unprognostic (5.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.19e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.14e-1)"	"unprognostic (3.72e-1)"	"unprognostic (2.86e-1)"	2.3	4.3	1.3	0.5	1.2	0.0	7.5	21.9	2.0	0.4	0.3	2.2	0.5	0.1	0.1	0.2	0.1	0.2	0.7	1.6	0.3	0.1	0.0	0.1	0.8	2.8	6.1	0.9	0.1	0.0	0.3	0.0	3.7	1.4	0.5	68.7	2.9	0.3	5.7	2.0	1.1	0.2	3.2	0.4	0.7	0.1	2.1	0.4	1.2	0.6	0.3	0.8	0.9	0.6	0.0	0.0	0.7	0.0	0.0	0.0	0.1	36.6	29.9	41.7	23.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.6	0.1	44.9	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.2	0.0	0.1	86.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	3.6	133.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.3	0.0	1.5	0.0	0.0	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	21.9	2.0	1.6	0.3	2.8	6.1	3.7	3.2	2.1	0.6	2.6	0.0	0.0	0.0	0.0	0.8	0.5	0.6	0.0	57.7	0.2	0.9	0.5	0.0	0.0	0.0	50.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.9	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.0	2.5	1.2	0.7	0.0	0.1	87.5	0.2	0.0	0.0	0.0	0.4	0.0	0.3	0.4	1.8	0.0	0.0	151.1	0.0	1.5	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	125.8	0.0	5.6	3.1	0.0	0.0	0.0	0.6	0.0	0.1	0.5	0.0	0.3
MAPRE2	"EB1, EB2, RP1"	ENSG00000166974	"Microtubule associated protein RP/EB family member 2"	Q15555	18	34976928-35143470	"Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 163.3;Oligodendrocytes: 435.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 124.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016738, HPA016739"	Enhanced		Uncertain	Nucleoplasm		NA	NA		13000000	"Cluster 44: Non-specific - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA016738: AB_1853571, HPA016739: AB_1853570"	"unprognostic (2.01e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.13e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.22e-3)"	"unprognostic (5.83e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.16e-2)"	"unprognostic (3.99e-3)"	22.4	58.7	54.2	29.1	65.2	22.1	16.6	58.5	89.4	19.3	1.9	24.5	15.0	14.0	18.9	17.4	12.7	41.1	89.1	68.8	56.9	18.4	33.4	27.2	35.8	74.0	61.0	24.9	12.8	19.2	16.3	28.3	70.6	16.1	24.6	49.1	20.2	17.2	50.4	26.1	19.6	23.8	70.0	27.8	30.6	6.4	68.2	74.4	21.7	91.9	32.6	27.2	14.4	109.0	0.8	26.3	28.9	15.4	17.1	15.9	2.0	18.7	44.7	22.3	37.2	2.0	9.9	87.8	21.3	41.1	23.5	35.0	22.8	15.2	39.8	51.5	21.3	88.9	26.9	52.8	12.6	49.5	72.3	19.6	4.0	30.4	10.5	21.2	124.0	61.4	28.3	37.7	28.8	1.7	104.6	16.4	22.5	28.8	5.2	41.6	35.2	20.0	11.9	0.4	35.9	23.9	14.0	0.7	15.5	27.2	3.2	29.0	21.0	24.1	13.4	14.2	12.7	19.9	50.8	50.8	41.4	65.1	38.2	69.0	30.0	46.7	63.8	37.7	49.5	60.8	44.4	58.3	33.4	55.5	50.6	61.5	21.5	74.4	51.6	47.3	52.9	76.9	54.2	65.2	58.5	89.4	68.8	56.9	74.0	61.0	70.6	70.0	68.2	109.0	27.0	22.4	18.3	104.8	73.0	23.7	5.1	2.0	38.1	109.6	18.9	19.7	105.6	12.8	4.8	5.5	25.0	0.6	107.9	13.3	5.9	9.8	12.4	11.9	12.6	29.4	29.3	25.0	163.3	12.8	9.7	28.5	42.3	14.6	27.3	4.6	33.5	26.1	26.1	52.2	141.7	25.8	4.1	44.7	38.3	6.8	19.3	44.6	30.2	70.3	17.1	40.3	52.5	97.5	435.9	10.1	15.6	21.1	31.6	2.9	12.0	5.1	6.5	12.5	78.9	25.4	74.9	1.9	10.6	9.1	27.6	0.8	76.1	15.0	11.1	3.5
MATN2		ENSG00000132561	"Matrilin 2"	O00339	8	97868840-98036724	"Predicted intracellular proteins, Predicted secreted proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 201.0;Peritubular cells: 258.8;Theca cells: 297.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 5.2"	"Lineage enriched"	"Detected in single"	7	"T-cells: 5.2"	"Cell line enhanced"	"Detected in many"		"BJ: 72.5;BJ hTERT+ SV40 Large T+: 78.6;BJ hTERT+ SV40 Large T+ RasG12V: 106.7;HaCaT: 114.4;HBF TERT88: 100.6;SuSa: 67.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033879	Approved				"Secreted to extracellular matrix"	NA	NA		1500000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 52: Non-specific - Transcription"			"CAB033879: AB_2141502"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"unprognostic (9.99e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.98e-1)"	"unprognostic (5.35e-2)"	"unprognostic (7.18e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.07e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (9.65e-4)"	"unprognostic (6.65e-2)"	54.4	51.0	24.3	30.2	22.5	1.8	43.6	17.6	23.2	194.4	19.3	67.5	58.5	147.0	101.6	32.8	46.9	40.1	110.2	20.0	23.4	39.3	24.6	15.2	18.0	24.1	30.5	116.4	11.3	28.0	9.9	177.9	26.3	104.9	57.8	45.7	42.6	171.9	4.0	62.8	80.6	98.1	18.3	5.9	23.7	31.2	23.4	4.9	271.4	28.5	15.4	103.0	139.2	30.8	24.1	10.8	23.3	2.5	60.7	3.6	15.0	72.5	17.6	78.6	106.7	13.0	8.4	0.1	7.0	29.2	3.5	114.4	2.3	4.4	100.6	0.0	2.9	0.8	6.1	0.9	14.0	0.0	0.0	13.6	9.5	16.1	0.8	22.1	0.5	1.3	0.1	0.2	4.1	11.2	0.0	0.7	7.1	0.3	3.7	0.0	2.4	11.4	5.7	5.3	16.0	1.5	11.5	0.2	19.8	67.3	10.9	1.4	0.6	5.2	31.5	16.1	11.0	0.9	0.2	0.2	18.8	0.4	5.9	0.0	0.1	0.1	0.2	0.4	5.2	0.0	0.7	0.9	0.8	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	24.3	22.5	17.6	23.2	20.0	23.4	24.1	30.5	26.3	18.3	23.4	30.8	27.8	3.2	1.3	11.1	0.3	37.3	10.1	6.2	80.2	6.3	3.8	45.8	29.1	18.6	3.0	16.5	54.2	1.2	0.2	20.6	0.0	9.9	86.0	4.2	22.6	32.4	23.4	3.2	6.4	0.0	1.1	113.1	5.1	5.0	0.0	43.5	201.0	11.0	1.6	0.0	11.5	25.4	0.0	5.0	7.7	108.6	103.5	0.9	28.4	19.7	2.0	8.1	0.0	86.0	59.8	3.2	18.2	258.8	0.0	6.5	118.7	3.4	1.6	52.9	13.1	97.2	17.1	2.5	2.6	7.3	8.5	2.5	2.0	297.5	27.4	1.8
MCF2L2	"ARHGEF22, KIAA0861"	ENSG00000053524	"MCF.2 cell line derived transforming sequence-like 2"	Q86YR7	3	183178043-183428778	"Disease related genes, Predicted intracellular proteins"		"Guanine-nucleotide releasing factor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 33.5;retina: 28.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 79.0;Cone photoreceptor cells: 221.0;Early spermatids: 92.9;Excitatory neurons: 177.2;Inhibitory neurons: 149.9;Oligodendrocyte precursor cells: 185.5;Oligodendrocytes: 69.1;Rod photoreceptor cells: 124.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"T-reg: 1.6"	"Lineage enriched"	"Detected in single"	15	"T-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.0;Karpas-707: 5.0;REH: 3.4"					"Low region specificity"	"Detected in all"			"HPA038946, HPA038947, HPA061485"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Centriolar satellite, Cytosol"		"HPA038946: AB_10670914, HPA038947: AB_10672655, HPA061485: "	"unprognostic (2.17e-2)"	"unprognostic (4.42e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.08e-2)"	"unprognostic (4.80e-4)"	"unprognostic (1.32e-1)"	"unprognostic (8.75e-6)"	"unprognostic (1.09e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.78e-1)"	0.1	7.7	9.4	0.3	16.5	0.2	0.1	0.3	33.5	0.3	0.0	0.5	0.0	0.2	0.2	0.2	0.2	0.3	0.2	13.5	6.5	0.4	0.0	0.2	0.5	6.9	6.1	0.2	0.2	3.8	5.4	0.0	7.2	0.6	0.3	28.2	0.1	0.4	0.3	0.2	0.3	0.3	0.0	2.5	0.2	2.6	5.6	0.3	0.1	0.2	0.7	0.4	0.3	19.8	0.0	0.4	0.1	1.1	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.7	0.1	1.0	0.1	0.0	1.2	0.0	0.2	0.1	0.0	6.0	0.9	2.5	0.2	0.0	0.1	0.8	0.5	0.1	0.0	0.0	0.4	0.0	0.4	1.5	0.8	5.0	0.3	0.7	0.8	0.5	0.8	0.0	1.0	3.4	0.0	0.9	0.2	0.1	1.5	0.5	0.6	0.0	1.3	0.3	0.3	0.5	0.3	0.0	0.5	0.0	0.0	2.0	2.3	1.1	0.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.6	0.0	9.4	16.5	0.3	33.5	13.5	6.5	6.9	6.1	7.2	0.0	5.6	19.8	12.3	0.0	2.2	17.0	0.2	0.4	0.5	0.2	8.6	79.0	0.3	0.6	1.8	0.0	0.1	5.5	221.0	0.2	0.8	2.1	0.0	0.1	92.9	4.6	2.1	2.0	0.0	0.4	177.2	0.2	0.1	2.0	5.1	4.3	1.3	7.7	1.8	0.4	0.5	8.4	149.9	0.3	2.0	0.8	1.2	16.4	0.9	4.3	1.8	43.1	1.6	3.8	1.0	185.5	69.1	0.1	2.2	0.4	0.6	0.3	0.4	0.1	2.8	124.0	0.0	4.1	0.9	1.4	4.2	11.2	0.4	1.4	2.9	2.9	0.2	1.1
MX2	MXB	ENSG00000183486	"MX dynamin like GTPase 2"	P20592	21	41361999-41409393	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Gastric mucus-secreting cells: 40.8;Macrophages: 57.6;monocytes: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 150.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 150.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 143.6;BJ hTERT+ SV40 Large T+ RasG12V: 136.9;MOLT-4: 56.8;U-266/84: 84.2;U-937: 90.6"					"Low region specificity"	"Detected in all"			HPA030235	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA030235: AB_10601970"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.90e-3)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (2.50e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.38e-14)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.16e-2)"	12.5	1.4	0.5	16.3	0.6	13.2	9.7	0.6	1.0	11.9	0.6	5.3	6.8	2.5	0.9	6.0	5.0	13.4	7.1	0.6	0.6	3.4	2.3	6.7	14.2	3.5	1.3	3.3	2.4	1.5	1.4	5.0	1.6	2.7	2.9	0.0	5.9	1.6	2.4	4.8	9.5	5.8	4.5	24.8	13.1	2.3	1.0	30.4	4.4	4.2	14.0	14.8	6.7	1.3	0.3	0.0	0.0	0.0	3.4	6.5	0.0	0.0	19.9	143.6	136.9	0.0	31.1	0.0	0.0	1.9	27.6	0.0	0.0	0.0	4.9	1.1	0.0	30.4	0.0	20.3	0.8	1.1	0.0	11.9	0.0	2.7	0.0	0.0	0.0	0.9	1.4	18.3	0.0	0.0	56.8	23.0	36.1	7.1	0.0	8.6	0.0	4.5	0.0	3.8	0.0	0.0	2.4	0.0	2.5	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	84.2	1.2	3.9	90.6	15.3	6.0	31.4	24.4	11.7	37.5	14.7	13.8	19.0	14.1	22.6	11.5	19.1	13.2	150.8	7.4	35.9	10.8	16.3	21.8	0.5	0.6	0.6	1.0	0.6	0.6	3.5	1.3	1.6	4.5	1.0	1.3	32.1	6.4	7.1	0.0	28.4	4.1	2.2	1.2	2.2	0.1	1.8	2.3	3.7	0.0	9.8	1.8	0.0	0.4	27.2	1.4	1.9	0.8	0.5	0.9	9.5	15.6	3.0	1.3	1.0	2.9	1.3	19.7	40.8	0.9	12.6	1.0	3.3	0.2	15.1	0.0	0.4	3.2	0.0	28.6	27.4	1.7	6.8	57.6	10.6	5.6	42.4	0.2	24.7	1.0	0.3	5.2	1.1	4.1	10.3	2.7	4.6	0.1	9.1	0.3	26.3	2.6	11.1	1.4	7.3	3.5	1.4	0.3	30.3	2.2	2.1	5.8
PAPPA	"ASBABP2, DIPLA1, IGFBP-4ase, PAPA, PAPP-A, PAPPA1"	ENSG00000182752	"Pappalysin 1"	Q13219	9	116153791-116402321	"Cancer-related genes, Candidate cardiovascular disease genes, Enzymes, Plasma proteins, Predicted secreted proteins"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"placenta: 72.3"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 92.2;Collecting duct cells: 165.5;Endometrial stromal cells: 101.3;Proximal tubular cells: 51.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 50.0;ASC TERT1: 37.8;HSkMC: 137.4;U-138 MG: 36.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA001667, CAB016724"	Enhanced				"Secreted in female reproductive system"	NA	NA		78000000		"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB016724: , HPA001667: AB_1854960"	"unprognostic (3.25e-1)"	"unprognostic (6.18e-6)"	"unprognostic (2.47e-1)"	"unprognostic (6.49e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.42e-3)"	"unprognostic (5.44e-2)"	"unprognostic (3.87e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.25e-2)"	"unprognostic (8.00e-3)"	"unprognostic (2.37e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.02e-3)"	4.1	1.5	0.7	1.8	0.2	0.0	0.8	0.5	0.9	4.2	2.2	2.0	0.3	3.9	0.6	2.5	3.1	2.0	2.6	0.3	1.6	3.8	0.3	1.9	1.2	2.5	2.5	2.5	0.8	9.1	0.4	72.3	2.0	1.1	1.5	1.0	0.4	2.1	0.3	0.9	0.9	4.2	0.4	0.3	1.1	0.8	1.6	0.8	1.0	1.4	1.0	4.5	2.4	1.3	0.0	14.9	22.3	0.0	50.0	37.8	0.0	12.2	21.4	3.3	5.6	0.0	0.0	0.0	0.0	8.6	1.1	1.7	0.0	0.0	15.6	0.0	0.0	2.6	12.8	0.1	24.3	0.0	0.0	137.4	0.0	16.4	1.9	26.9	0.1	0.0	0.5	0.0	3.8	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.6	0.0	0.6	0.1	0.1	1.2	1.8	0.0	0.0	6.8	0.0	0.0	28.9	36.3	1.8	1.0	1.4	0.0	0.0	0.0	25.8	0.0	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.2	0.5	0.9	0.3	1.6	2.5	2.5	2.0	0.4	1.6	1.3	0.2	0.0	1.5	3.9	1.0	2.9	0.2	4.0	92.2	17.6	0.8	0.4	3.4	0.0	1.6	165.5	12.5	0.5	0.1	0.1	9.8	5.9	20.1	4.7	101.3	1.4	0.0	0.0	10.0	0.9	19.5	31.8	0.5	2.6	1.3	10.4	4.6	0.1	0.4	0.0	19.6	0.0	0.0	0.0	5.8	17.9	14.3	1.0	1.8	7.5	0.0	2.5	1.0	15.1	2.9	0.3	0.0	8.6	1.2	1.2	0.2	51.5	1.6	2.9	0.0	3.3	10.9	2.2	0.6	19.7	1.1	14.0	1.3	0.2	0.1	0.3
PCDH9		ENSG00000184226	"Protocadherin 9"	Q9HC56	13	66302834-67230445	"Plasma proteins, Predicted membrane proteins"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"brain: 159.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 4339.5;Excitatory neurons: 5259.8;Inhibitory neurons: 2489.4;Oligodendrocyte precursor cells: 6313.8;Oligodendrocytes: 14117.8"	"Cancer enriched"	"Detected in single"	8	"glioma: 2.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"basophil: 4.5;memory B-cell: 5.3;naive B-cell: 17.3"	"Group enriched"	"Detected in many"	9	"B-cells: 17.3;granulocytes: 4.5"	"Cell line enhanced"	"Detected in many"		"AF22: 25.1;LHCN-M2: 41.6;TIME: 48.9;U-698: 64.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015581			Approved	Nucleoplasm,Centrosome		NA	NA		2900000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Centrosome"		"HPA015581: AB_1855048"	"unprognostic (1.77e-1)"	"unprognostic (8.36e-2)"	"unprognostic (9.12e-3)"	"unprognostic (4.42e-5)"	"unprognostic (7.54e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.35e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.47e-4)"	"unprognostic (6.44e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.35e-4)"	3.8	2.2	37.1	0.4	84.0	3.3	1.0	41.5	53.2	0.9	0.0	1.2	0.2	0.2	1.2	0.3	0.4	1.5	4.9	37.8	51.3	2.5	1.5	1.5	0.7	49.9	52.1	0.6	1.3	0.0	2.0	0.0	56.8	1.6	0.5	9.4	0.3	4.2	1.3	0.2	0.5	0.5	27.1	0.9	1.9	0.9	76.1	2.2	1.0	1.1	0.6	0.7	1.0	159.3	0.0	19.3	25.1	0.0	6.6	5.1	0.0	3.8	0.2	2.7	1.0	0.1	0.1	5.7	0.1	2.9	0.9	0.0	2.1	0.6	1.2	0.0	10.1	0.3	0.2	0.0	6.3	0.7	0.3	12.1	0.7	3.1	5.0	0.6	2.1	2.2	0.6	0.3	41.6	1.6	12.2	0.0	0.2	0.5	2.5	18.2	0.8	0.0	0.5	0.0	3.2	1.3	0.0	0.1	0.3	0.6	0.0	0.1	48.9	1.4	1.2	5.9	2.0	7.3	0.0	64.2	10.6	0.0	5.0	4.5	0.0	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	17.3	0.1	0.1	0.1	0.9	0.0	1.2	0.0	0.2	37.1	84.0	41.5	53.2	37.8	51.3	49.9	52.1	56.8	27.1	76.1	159.3	5.6	19.2	68.0	4339.5	29.1	1.9	2.5	0.0	1.8	318.8	9.2	14.7	152.5	0.0	4.4	5.5	20.9	0.2	4.3	0.9	9.8	1.9	3.6	0.3	6.4	4.7	62.4	2.5	5259.8	0.0	0.2	76.3	11.7	0.3	1.3	1.0	19.2	8.6	0.3	198.5	2489.4	1.4	0.0	1.9	1.4	3.0	29.5	3.7	10.6	237.0	0.3	87.8	2.1	6313.8	14117.8	0.3	1.2	14.7	1.4	2.0	0.0	0.8	0.0	27.1	6.6	27.9	25.4	6.8	5.4	1.2	0.3	0.0	2.7	3.7	0.8	0.8
PDGFA	"PDGF-A, PDGF1"	ENSG00000197461	"Platelet derived growth factor subunit A"	P04085	7	497258-520296	"Cancer-related genes, Candidate cardiovascular disease genes, Human disease related genes, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins"		"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 95.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 89.8;Breast myoepithelial cells: 154.9;Paneth cells: 97.0;Smooth muscle cells: 110.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 11.3"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in many"	4	"WM-115: 311.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005579, HPA065024"	Approved		Approved	"Golgi apparatus"	"Secreted to blood"	NA	NA		580000	"Cluster 42: Non-specific - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"	"Golgi apparatus"		"CAB005579: AB_2161916, HPA065024: "	"unprognostic (2.22e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.75e-4)"	"prognostic unfavorable (1.78e-4)"	"unprognostic (2.63e-3)"	"unprognostic (4.37e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.07e-2)"	"unprognostic (5.87e-2)"	"unprognostic (8.35e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (8.67e-4)"	15.4	8.5	29.3	7.9	36.8	1.7	17.0	36.6	32.4	18.1	20.5	29.2	20.2	26.1	11.2	9.6	21.2	11.4	21.1	27.0	27.5	22.2	8.5	24.9	3.5	46.4	37.5	7.7	71.6	6.6	10.2	26.8	40.7	23.3	14.8	5.2	20.3	11.2	95.2	12.5	25.9	10.2	35.8	16.3	32.1	4.5	36.5	6.6	10.0	15.1	2.4	17.8	15.9	58.8	22.9	15.3	1.5	21.6	4.1	0.7	50.7	5.0	2.9	6.4	4.4	23.8	25.3	0.6	8.7	4.3	2.9	56.6	1.5	69.0	3.4	12.9	2.3	0.3	13.3	8.7	26.9	2.4	2.2	3.0	26.8	3.3	21.3	8.5	12.5	1.3	2.3	3.1	15.8	28.7	3.5	5.0	40.1	8.9	3.3	11.6	1.5	2.5	9.0	5.3	2.1	1.8	76.5	4.2	13.3	47.5	10.7	2.6	37.3	13.6	37.8	8.0	31.0	0.9	1.4	0.8	12.3	7.1	311.4	11.3	1.6	2.4	1.6	1.9	2.2	1.9	1.6	1.5	1.5	1.8	1.9	2.0	4.9	3.4	3.3	2.1	1.8	2.1	29.3	36.8	36.6	32.4	27.0	27.5	46.4	37.5	40.7	35.8	36.5	58.8	15.2	89.8	11.9	11.1	1.5	28.0	20.2	12.1	59.7	15.7	12.7	154.9	29.9	15.7	11.0	14.7	8.4	8.8	1.7	76.9	5.9	15.8	0.3	49.0	4.2	19.4	13.1	0.0	7.7	53.3	5.4	12.3	41.8	35.7	10.8	18.1	21.0	1.0	2.0	32.0	5.9	40.5	2.0	1.3	10.4	0.1	2.1	14.8	14.2	6.5	1.5	0.7	1.0	5.0	27.5	72.6	97.0	6.4	4.4	29.4	47.2	8.5	4.5	2.1	39.5	48.9	110.3	0.5	1.8	9.4	9.8	2.9	3.9	0.2	32.1	18.2
PRDM16	"KIAA1675, KMT8F, MEL1, MGC166915, PFM13"	ENSG00000142611	"PR/SET domain 16"	Q9HAZ2	1	3069168-3438621	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Differentiation, Transcription, Transcription regulation"	"Activator, DNA-binding, Methyltransferase, Repressor, Transferase"	"Cancer-related genes, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 16.2"	"Cell type enriched"	"Detected in many"	4	"Astrocytes: 173.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	16	"NK-cell: 2.4"	"Lineage enriched"	"Detected in single"	16	"NK-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"HEK 293: 1.8;HHSteC: 2.0;hTERT-RPE1: 6.7;MCF7: 1.6;OE19: 3.5"	"Region enriched"	"Detected in many"	5	"basal ganglia: 15.7"	"Low region specificity"	"Detected in many"			"HPA050343, HPA060467"			Supported	Nucleoplasm		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA050343: AB_2681099, HPA060467: AB_2684287"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.31e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.95e-2)"	"unprognostic (9.15e-3)"	"unprognostic (5.68e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.07e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.71e-1)"	"unprognostic (7.80e-6)"	"unprognostic (2.14e-1)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (4.70e-5)"	"unprognostic (4.06e-2)"	1.6	0.2	3.7	0.5	4.8	0.0	1.1	0.1	4.1	1.3	16.2	1.1	7.4	1.0	2.1	0.3	1.4	1.1	5.4	2.8	0.6	6.8	0.2	2.5	0.5	0.5	1.7	1.5	5.8	0.9	0.6	0.1	0.9	0.7	0.2	0.0	0.4	2.2	0.4	0.5	2.6	0.2	0.0	2.1	9.3	0.7	4.1	0.1	8.0	0.6	0.3	0.9	1.1	1.5	0.0	0.0	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.3	0.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.1	1.8	0.0	0.0	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.1	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	3.7	4.8	0.1	4.1	2.8	0.6	0.5	1.7	0.9	0.0	4.1	1.5	4.5	35.3	10.5	173.7	0.1	0.6	0.3	2.1	0.6	0.1	0.2	0.3	5.2	22.8	6.3	7.3	0.0	0.0	0.1	0.2	5.9	10.0	0.3	0.2	0.0	2.1	5.4	0.8	1.2	4.9	4.2	0.6	30.5	0.4	0.0	0.3	0.0	0.0	0.0	1.7	1.0	0.9	0.0	0.0	0.4	0.2	1.5	0.1	0.0	14.0	0.0	1.4	0.0	6.6	1.8	7.1	0.8	1.9	0.1	0.8	0.5	0.2	1.9	0.3	0.0	3.3	9.0	0.3	1.8	0.2	0.0	0.0	0.4	0.0	1.5	0.2
PSD2	"DKFZp761B0514, EFA6C"	ENSG00000146005	"Pleckstrin and Sec7 domain containing 2"	Q9BQI7	5	139795808-139844466	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 106.3"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 229.9"	"Cancer enriched"	"Detected in single"	43	"glioma: 19.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"THP-1: 1.1;U-2 OS: 1.1;U-698: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054625			Approved	"Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA054625: "	"unprognostic (3.76e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.34e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.34e-2)"	"unprognostic (5.01e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.55e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.16e-3)"	"unprognostic (3.40e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.07e-1)"	"unprognostic (2.12e-3)"	0.1	0.3	70.8	0.3	91.3	0.2	0.5	86.5	63.1	0.8	22.0	0.2	0.1	0.2	1.6	0.0	0.4	0.2	0.2	58.7	76.3	0.1	0.1	0.1	0.0	90.6	106.2	0.1	0.4	0.0	0.9	0.0	79.2	0.2	0.1	4.1	1.7	0.4	0.3	0.1	0.1	0.1	70.5	0.2	0.1	1.1	106.3	1.0	0.1	0.0	0.1	0.1	0.2	56.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.5	0.9	0.0	0.2	0.0	0.0	0.0	1.1	0.0	0.3	1.1	0.0	0.0	0.2	0.0	1.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	70.8	91.3	86.5	63.1	58.7	76.3	90.6	106.2	79.2	70.5	106.3	56.3	0.0	0.0	0.0	229.9	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	9.1	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.5	0.0	2.6	0.0	52.8	24.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.6	0.0	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PURG	"PURG-A, PURG-B"	ENSG00000172733	"Purine rich element binding protein G"	Q9UJV8	8	30995802-31033715	"Predicted intracellular proteins, Transcription factors"		DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.5;retina: 4.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 61.0;Excitatory neurons: 57.2;Inhibitory neurons: 69.5;Late spermatids: 22.0;Oligodendrocyte precursor cells: 49.3;Oligodendrocytes: 27.8"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.1;JURKAT: 4.3;NTERA-2: 4.8;SH-SY5Y: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047746	Enhanced		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Plasma membrane"	Nucleoli	"HPA047746: AB_2680145"	"unprognostic (3.37e-1)"	"unprognostic (2.15e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.33e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.79e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.30e-2)"	0.3	0.4	7.7	0.2	8.3	0.0	0.2	10.5	9.0	1.3	0.5	0.3	0.1	2.0	0.6	0.2	0.4	0.8	0.4	8.7	7.7	0.4	0.0	0.2	0.2	6.6	6.7	0.5	0.0	0.0	3.0	0.2	7.4	0.5	0.1	4.1	0.3	0.6	0.1	0.0	0.2	1.3	6.1	0.6	0.2	2.6	7.3	0.1	0.2	0.2	0.1	0.2	0.8	6.5	0.0	0.0	6.1	0.1	0.0	0.0	0.0	0.1	0.3	0.5	1.2	0.0	0.0	0.1	0.0	0.0	2.1	0.0	2.0	0.0	0.7	0.0	3.1	1.1	0.0	0.2	0.0	0.0	0.1	0.9	0.0	0.9	0.0	0.7	3.0	4.3	0.3	0.4	0.1	0.0	0.6	0.0	4.8	0.0	0.2	1.6	0.8	0.0	0.0	0.0	0.8	5.7	0.0	0.0	0.0	2.2	0.0	0.0	1.9	2.0	2.5	0.0	0.3	0.2	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	8.3	10.5	9.0	8.7	7.7	6.6	6.7	7.4	6.1	7.3	6.5	0.5	0.0	0.0	61.0	0.0	0.0	0.0	0.0	0.0	13.3	0.1	0.3	0.6	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	17.3	0.2	3.2	0.5	0.0	0.0	57.2	0.0	0.0	1.1	0.0	0.1	0.0	3.6	0.0	0.0	0.0	20.2	69.5	0.0	0.0	0.0	0.3	22.0	0.6	0.1	0.0	12.2	0.0	10.8	0.0	49.3	27.8	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.3	1.3	4.2	1.5	0.0	0.0	0.0	0.1	1.8	0.0	0.0
REM1	"GES, REM"	ENSG00000088320	"RRAD and GEM like GTPase 1"	O75628	20	31475288-31484895	"Predicted intracellular proteins"		Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 20.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.7;Peritubular cells: 11.7;Sertoli cells: 59.2;Smooth muscle cells: 28.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	32	"WM-115: 22.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"cerebellum: 4.6"	HPA049821	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA049821: AB_2680898"	"unprognostic (6.16e-2)"	"unprognostic (3.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (9.65e-2)"	"unprognostic (6.03e-3)"	"unprognostic (1.84e-2)"	"unprognostic (4.39e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.88e-2)"	"unprognostic (4.77e-3)"	"unprognostic (8.03e-2)"	"prognostic unfavorable (1.84e-6)"	"unprognostic (7.79e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.06e-2)"	13.9	2.2	1.2	1.7	1.1	0.0	7.5	0.9	2.1	20.1	1.3	6.5	1.3	10.5	7.2	2.0	10.0	2.2	6.2	1.0	1.0	3.2	0.8	4.6	3.0	1.0	1.1	3.9	1.1	1.1	2.7	2.1	1.1	5.5	1.0	0.0	1.6	4.9	3.3	3.2	3.7	3.2	0.9	2.5	2.4	1.4	1.3	0.7	4.8	2.4	1.5	4.8	9.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	1.1	0.9	2.1	1.0	1.0	1.0	1.1	1.1	0.9	1.3	1.0	7.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.4	1.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	7.1	2.3	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.2	0.0	0.0	2.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.6	5.6	0.3	3.6	1.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.0	0.8	0.0	59.2	0.6	28.1	0.0	0.2	0.1	0.9	0.0	0.1	1.5	0.0	0.0
RHBDF1	"C16orf8, Dist1, EGFR-RS, FLJ2235, iRhom1"	ENSG00000007384	"Rhomboid 5 homolog 1"	Q96CC6	16	58059-76355	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Protein transport, Transport"	"Growth factor binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 66.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077399			Uncertain	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA077399: "	"unprognostic (2.62e-1)"	"unprognostic (2.86e-2)"	"unprognostic (4.76e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.60e-3)"	"unprognostic (4.54e-3)"	"unprognostic (4.51e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.81e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.81e-2)"	"unprognostic (1.87e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.22e-2)"	41.9	11.5	14.5	6.0	14.4	0.5	44.3	13.5	19.5	65.1	13.3	38.2	7.5	38.1	13.0	47.0	36.4	22.1	51.7	14.3	13.5	24.7	13.2	58.5	5.5	14.5	14.4	55.6	23.4	8.9	13.3	27.5	13.9	61.2	7.1	2.5	38.3	16.5	34.1	46.1	24.8	10.5	14.0	19.3	28.5	8.0	14.7	1.2	33.4	16.9	5.5	44.6	61.4	13.5	10.8	17.3	9.7	22.5	37.2	45.7	31.8	29.1	53.8	20.1	19.1	23.5	36.9	0.6	11.8	31.1	10.2	33.6	4.8	19.6	3.4	0.5	5.3	0.4	18.8	6.6	41.4	0.3	18.3	38.3	20.3	51.9	8.6	35.5	31.4	0.1	4.1	0.4	32.2	60.6	0.1	3.5	8.8	22.7	14.5	0.3	11.5	0.9	22.7	11.0	0.3	2.4	8.4	31.8	18.7	11.9	49.1	3.8	32.6	31.5	21.9	24.8	8.1	0.2	0.7	0.3	22.0	0.6	50.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.5	14.4	13.5	19.5	14.3	13.5	14.5	14.4	13.9	14.0	14.7	13.5	10.5	19.2	6.2	9.1	0.3	6.8	9.9	15.2	5.2	0.8	17.8	13.5	9.9	22.8	15.8	9.2	66.7	19.0	0.3	21.9	0.0	21.4	1.1	3.8	9.9	9.2	0.0	0.0	1.7	8.0	16.3	20.6	15.8	11.2	0.0	8.7	8.2	3.0	2.2	0.0	0.6	9.8	18.3	0.6	5.1	1.1	19.6	0.4	16.0	5.6	0.0	6.9	0.0	16.6	0.7	28.4	13.6	13.9	0.2	25.8	2.1	2.3	5.3	4.9	13.1	10.8	22.3	0.3	1.9	6.6	5.5	30.6	0.8	16.4	3.8	17.9
RNF144A	"hUIP4, KIAA0161, RNF144, UBCE7IP4"	ENSG00000151692	"Ring finger protein 144A"	P50876	2	6917412-7068286	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 73.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 176.6;Inhibitory neurons: 101.7;Oligodendrocyte precursor cells: 194.5;Oligodendrocytes: 330.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 6.1"	"Group enriched"	"Detected in many"	7	"granulocytes: 6.1;T-cells: 2.4"	"Cell line enhanced"	"Detected in many"		"HEL: 39.7;HMC-1: 127.9;SH-SY5Y: 39.0;SK-MEL-30: 39.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049939	Approved		Supported	Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA049939: AB_2680960"	"unprognostic (1.78e-1)"	"unprognostic (2.53e-3)"	"unprognostic (8.37e-2)"	"prognostic unfavorable (6.00e-4)"	"unprognostic (6.57e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (7.04e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"unprognostic (5.64e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (7.32e-5)"	"unprognostic (1.30e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.82e-3)"	9.7	28.5	21.1	4.1	46.1	13.9	10.1	59.2	36.7	24.2	1.2	5.7	2.6	26.3	7.7	4.3	7.8	7.1	8.1	17.5	24.0	7.3	1.3	5.4	6.0	30.1	27.0	19.3	30.7	38.1	12.9	5.9	33.4	9.1	5.3	23.0	4.6	6.4	9.6	5.4	3.8	11.6	21.5	23.0	2.6	4.7	30.3	7.5	3.4	10.1	5.6	4.4	7.5	73.6	0.8	5.8	30.1	6.2	6.6	13.6	23.0	0.2	0.0	1.1	2.8	0.1	0.7	2.9	3.3	0.3	8.7	0.7	10.0	0.0	0.0	1.6	2.6	39.7	0.3	11.8	0.3	0.7	127.9	21.7	0.1	2.2	0.0	0.0	0.0	9.9	17.3	0.6	0.0	4.9	20.6	1.7	11.0	0.7	13.6	15.9	21.8	2.6	1.0	10.2	9.9	39.0	0.5	4.0	39.8	3.9	1.7	2.6	0.1	3.9	10.0	10.7	4.5	10.4	3.5	0.1	14.7	8.7	14.3	1.3	0.0	6.1	1.2	0.0	1.8	0.0	1.3	0.9	0.1	0.1	2.4	1.7	0.3	0.5	0.0	0.0	0.6	0.4	21.1	46.1	59.2	36.7	17.5	24.0	30.1	27.0	33.4	21.5	30.3	73.6	27.8	3.2	4.2	34.3	2.4	2.4	0.7	0.0	1.8	4.6	2.5	2.5	11.5	2.8	1.9	0.0	75.0	2.4	5.3	15.4	1.9	3.3	5.5	6.1	15.4	13.9	25.4	18.5	176.6	5.8	3.1	10.4	2.6	10.7	8.9	31.5	23.2	1.1	4.9	10.1	101.7	2.7	0.0	1.0	1.7	14.2	4.4	1.7	24.9	17.8	1.2	7.6	10.3	194.5	330.3	3.0	11.1	10.5	3.1	3.0	2.0	0.3	1.5	39.8	0.0	16.1	5.2	1.8	6.6	5.2	1.6	1.1	9.8	19.1	2.7	1.7
SCN7A	"NaG, Nav2.1, Nav2.2, SCN6A"	ENSG00000136546	"Sodium voltage-gated channel alpha subunit 7"	Q01118	2	166403573-166611482	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 45.4"	"Group enriched"	"Detected in many"	4	"Fibroblasts: 102.0;Leydig cells: 100.9;Peritubular cells: 159.9;Sertoli cells: 151.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.1"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.1"	"Group enriched"	"Detected in some"	5	"HDLM-2: 7.9;HMC-1: 4.5;Karpas-707: 5.8;SK-BR-3: 15.4"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 7.6"	HPA072715	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA072715: "	"unprognostic (1.22e-1)"	"unprognostic (6.42e-3)"	"unprognostic (9.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.00e-3)"	"unprognostic (5.21e-2)"	"unprognostic (6.84e-3)"	"unprognostic (6.88e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-4)"	4.6	8.6	3.4	3.4	3.0	0.3	10.2	0.1	1.8	7.8	0.0	35.8	3.4	9.0	6.3	10.1	10.9	3.8	20.6	1.1	7.1	1.8	1.2	27.6	0.5	4.0	7.1	45.4	4.9	0.7	1.0	12.3	5.4	11.0	8.5	10.6	6.1	10.1	7.2	2.4	6.8	7.6	2.9	3.2	7.8	5.6	9.8	3.2	1.2	15.0	0.4	4.7	7.1	1.2	0.1	0.1	0.7	0.9	0.2	0.0	0.8	0.7	0.0	1.3	0.0	0.6	0.2	0.4	0.1	0.0	0.3	0.3	0.1	0.1	0.0	7.9	0.5	0.2	1.5	0.6	0.0	0.2	4.5	0.0	0.0	0.4	0.1	0.4	0.0	0.4	1.2	5.8	0.0	1.0	0.8	0.5	1.1	0.3	0.3	0.0	0.5	0.0	0.1	0.8	0.2	0.4	0.3	15.4	0.0	0.3	0.4	0.1	0.4	0.2	1.0	0.7	0.4	1.0	0.3	1.1	0.2	0.2	0.4	1.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.8	3.4	3.0	0.1	1.8	1.1	7.1	4.0	7.1	5.4	2.9	9.8	1.2	1.4	0.0	1.1	1.0	0.0	0.3	0.2	0.0	5.7	21.5	0.2	0.3	16.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.9	0.0	2.4	0.0	0.3	4.1	0.0	0.0	7.7	0.0	0.0	102.0	0.0	0.0	15.9	0.1	9.3	0.0	0.2	0.0	20.9	0.0	0.0	0.0	1.2	4.1	100.9	1.8	5.4	14.0	0.0	4.9	0.0	14.1	0.3	0.1	0.0	159.9	1.2	0.5	0.0	0.5	0.0	1.8	151.2	16.7	26.1	0.5	1.2	1.7	1.1	0.0	0.2	0.3	0.0	0.3
SGIP1	DKFZp761D221	ENSG00000118473	"SH3GL interacting endocytic adaptor 1"	Q9BQI5	1	66533383-66751139	"Predicted intracellular proteins"	Endocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"retina: 131.4"	"Group enriched"	"Detected in many"	4	"Astrocytes: 390.1;Cone photoreceptor cells: 350.3;Excitatory neurons: 323.3;Inhibitory neurons: 401.5;Oligodendrocyte precursor cells: 482.0;Oligodendrocytes: 363.6;Rod photoreceptor cells: 344.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 29.9;BJ hTERT+: 38.0;fHDF/TERT166: 24.5;hTERT-RPE1: 15.8;RPTEC TERT1: 27.5;SH-SY5Y: 15.3;U-138 MG: 27.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017963	Approved		Approved	Mitochondria		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 9: Photoreceptor cells - Phototransduction"	Mitochondria		"HPA017963: AB_10964882"	"unprognostic (1.74e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.04e-2)"	"unprognostic (9.51e-2)"	"unprognostic (7.64e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.48e-7)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"	"unprognostic (4.25e-2)"	"unprognostic (9.63e-2)"	7.4	4.3	12.2	1.9	15.5	0.2	2.7	6.3	17.4	10.4	0.0	3.1	1.6	10.6	4.6	2.7	3.8	4.6	5.0	15.3	5.8	18.0	0.7	8.3	0.7	5.1	5.7	1.6	0.5	0.2	7.7	1.9	5.3	5.8	1.5	131.4	1.7	5.0	2.5	1.6	2.0	3.8	1.6	0.3	3.3	4.4	5.5	0.7	8.9	1.2	0.4	2.7	5.4	10.1	0.0	0.0	0.0	0.0	0.9	5.5	0.0	29.9	38.0	2.3	3.4	0.0	0.0	0.0	0.1	24.5	0.2	0.0	0.0	0.1	4.3	0.0	0.0	1.1	0.4	0.0	6.5	0.0	0.0	4.1	0.0	2.3	0.0	15.8	11.3	0.2	0.0	0.0	13.8	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	27.5	0.0	0.7	15.3	0.0	0.0	0.0	0.6	0.0	1.1	1.9	27.3	0.0	0.7	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	15.5	6.3	17.4	15.3	5.8	5.1	5.7	5.3	1.6	5.5	10.1	5.0	0.0	0.0	390.1	0.1	1.0	0.3	0.4	0.0	89.8	0.2	4.7	2.5	2.8	0.0	9.2	350.3	0.1	0.0	0.1	7.9	0.5	0.6	2.9	7.8	13.8	0.0	0.0	323.3	0.0	0.0	15.8	0.5	5.7	10.1	0.0	0.4	0.2	0.2	74.0	401.5	0.0	0.0	0.0	1.1	1.2	2.1	0.4	10.6	48.7	0.0	49.4	0.0	482.0	363.6	0.0	0.0	11.3	0.8	0.8	0.0	0.2	0.0	344.1	13.1	3.2	32.2	0.2	0.4	0.1	1.0	0.3	0.5	0.0	0.1	0.3
SHFL	"C19orf66, FLJ11286, IRAV, RyDEN, SFL"	ENSG00000130813	"Shiftless antiviral inhibitor of ribosomal frameshifting"	Q9NUL5	19	10086122-10093252	"Predicted intracellular proteins"	"Antiviral defense"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 75.7"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.3;dendritic cells: 21.7;Fibroblasts: 6.8;Hofbauer cells: 32.6;Plasma cells: 9.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 71.8;BJ hTERT+ SV40 Large T+ RasG12V: 81.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042001	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm	Cytosol	"HPA042001: AB_10794167"	"prognostic favorable (4.04e-4)"	"unprognostic (1.21e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.19e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.46e-1)"	"unprognostic (3.93e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.22e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.88e-1)"	"prognostic unfavorable (8.96e-11)"	"unprognostic (5.92e-2)"	"unprognostic (1.81e-1)"	"unprognostic (4.41e-3)"	"prognostic favorable (1.35e-4)"	12.8	18.5	27.1	14.2	27.4	15.7	12.2	26.3	30.1	17.0	24.4	12.8	14.8	15.8	16.5	8.6	17.6	18.1	8.2	27.2	28.5	14.0	75.7	16.8	22.8	27.3	27.0	18.9	9.9	16.7	14.1	12.7	27.2	11.9	9.9	15.0	16.3	19.1	4.4	9.5	18.4	15.4	28.8	19.9	11.0	4.3	29.5	20.4	12.2	6.9	16.6	14.7	12.3	28.1	9.4	3.8	5.0	3.9	20.3	23.6	1.4	7.6	46.3	71.8	81.2	0.4	7.4	4.8	2.1	24.0	25.7	3.9	3.9	20.7	12.0	30.4	0.4	15.5	3.0	10.6	32.6	4.7	9.7	34.3	11.7	11.5	4.1	27.1	22.9	20.6	1.8	20.2	15.0	6.5	20.1	13.3	1.1	7.0	5.5	16.2	0.0	8.0	14.8	13.0	0.7	3.5	12.9	1.3	42.2	0.9	1.2	12.9	14.8	6.0	3.0	9.6	1.6	24.1	7.2	1.2	16.8	6.0	12.1	16.4	12.8	18.2	23.3	11.7	31.1	13.0	19.5	25.4	10.2	10.1	16.3	17.7	16.4	32.7	20.3	2.0	21.7	15.5	27.1	27.4	26.3	30.1	27.2	28.5	27.3	27.0	27.2	28.8	29.5	28.1	23.3	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	5.4	21.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	6.7	6.8	0.0	0.0	0.0	0.0	0.0	0.0	32.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	2.6	3.3	0.0	0.0	0.0
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362851-110391082	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 124.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 71.7;Proximal tubular cells: 192.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 20.4;BJ hTERT+: 20.7;CAPAN-2: 30.8;HHSteC: 19.2;hTERT-RPE1: 42.6;SK-MEL-30: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	4.9	2.9	2.7	4.6	3.1	1.0	6.9	5.8	4.4	4.2	15.4	3.6	9.5	3.0	22.4	2.7	4.0	13.7	4.6	3.5	4.1	124.1	16.3	9.2	3.4	4.1	3.1	21.4	0.9	0.4	3.8	28.6	3.9	3.8	1.6	2.3	3.6	5.8	1.3	1.3	11.4	3.4	4.1	2.7	2.7	5.2	3.0	0.6	8.5	3.9	1.1	7.9	3.5	4.2	0.4	9.8	2.3	2.7	6.3	12.9	20.4	5.3	20.7	1.8	5.3	3.1	30.8	0.6	5.7	17.1	0.1	0.5	0.1	1.9	1.9	0.5	2.5	0.5	2.7	3.3	19.2	0.9	0.5	10.0	0.3	3.0	0.2	42.6	4.1	0.8	0.5	1.2	3.3	1.0	0.4	0.6	0.9	0.0	0.3	0.2	1.3	0.1	3.7	0.4	1.2	0.9	0.6	9.8	30.6	9.0	0.7	0.1	0.4	1.4	0.7	0.3	1.5	0.5	0.1	1.6	1.1	0.4	6.1	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	2.7	3.1	5.8	4.4	3.5	4.1	4.1	3.1	3.9	4.1	3.0	4.2	1.9	12.8	20.8	2.3	5.8	3.1	6.1	11.2	1.2	11.5	14.7	6.5	1.1	11.5	6.8	71.7	6.2	39.5	5.8	0.9	3.9	2.7	0.5	3.3	6.8	4.6	3.5	2.7	8.2	0.9	34.6	18.2	1.5	3.3	5.1	5.2	4.2	5.0	4.2	3.3	7.1	0.9	4.1	1.6	3.0	2.2	18.0	1.8	10.6	15.0	1.8	2.4	9.2	2.5	4.7	1.9	1.2	11.7	1.2	3.1	38.4	192.3	3.5	20.1	0.0	4.5	5.4	3.4	1.9	0.5	3.7	35.2	3.9	7.0	1.4	7.2
SOX2		ENSG00000181449	"SRY-box transcription factor 2"	P48431	3	181711925-181714436	"Cancer-related genes, Disease related genes, Human disease related genes, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"	"Cancer-related genes, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 62.2;esophagus: 24.5"	"Group enriched"	"Detected in some"	6	"Basal squamous epithelial cells: 362.0;Muller glia cells: 383.5;Squamous epithelial cells: 229.1"	"Cancer enhanced"	"Detected in many"		"glioma: 136.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 277.0;HAP1: 118.6;NTERA-2: 226.2;U-251 MG: 54.0"	"Low region specificity"	"Detected in all"							"HPA045725, HPA062851, HPA071379, CAB079745"	Enhanced	Supported	Enhanced	Nucleoplasm		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm		"CAB079745: , HPA045725: AB_2679431, HPA062851: , HPA071379: "	"unprognostic (1.80e-2)"	"unprognostic (3.18e-3)"	"unprognostic (5.69e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.71e-1)"	"unprognostic (4.38e-3)"	"unprognostic (1.83e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.81e-9)"	"unprognostic (1.12e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.12e-2)"	0.3	0.9	58.0	0.5	58.5	0.0	0.2	47.1	56.6	2.1	8.6	5.5	0.4	0.1	0.2	24.5	3.1	0.2	0.5	46.5	59.0	0.0	0.1	1.8	0.0	50.5	58.9	0.3	0.1	0.0	13.6	0.0	45.2	2.5	0.4	15.0	18.4	0.3	0.1	0.6	1.4	0.2	59.8	0.0	7.9	1.9	59.2	0.4	0.1	0.1	5.3	1.3	4.8	62.2	0.1	9.0	277.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.3	0.0	0.1	0.0	0.2	0.7	118.6	3.2	0.0	0.1	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	226.2	12.4	0.5	0.0	0.6	0.0	31.0	0.4	0.5	1.2	0.0	0.0	0.1	45.7	1.7	0.1	0.0	0.0	4.2	0.0	54.0	0.0	0.0	0.0	0.2	0.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.0	58.5	47.1	56.6	46.5	59.0	50.5	58.9	45.2	59.8	59.2	62.2	0.2	0.0	6.0	0.0	0.0	0.3	35.5	28.5	362.0	4.9	0.2	0.4	0.5	0.0	48.4	3.7	0.0	0.2	0.0	1.1	0.0	0.0	0.9	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.1	1.6	19.4	0.0	1.3	0.2	0.7	0.1	0.1	0.0	0.0	0.5	38.7	0.0	0.4	0.4	0.6	0.8	3.6	0.0	0.0	383.5	0.0	0.0	0.0	0.0	0.0	0.0	6.1	5.8	0.0	0.1	52.8	13.1	0.0	0.2	1.6	3.9	0.4	229.1	0.4	0.3	0.6	0.2	0.0	7.5
STOX2	DKFZp762K222	ENSG00000173320	"Storkhead box 2"	Q9P2F5	4	183797692-184023526	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 181.7;Inhibitory neurons: 192.3;Microglial cells: 72.1;Oligodendrocyte precursor cells: 91.0;Oligodendrocytes: 153.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.2;HeLa: 12.7;NTERA-2: 16.8;SH-SY5Y: 15.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049776, HPA065002"	Uncertain		Approved	"Nucleoplasm,Actin filaments,Cytosol"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Cytosol"	"Actin filaments"	"HPA049776: AB_2680875, HPA065002: "	"unprognostic (9.79e-3)"	"unprognostic (3.46e-1)"	"unprognostic (2.10e-1)"	"unprognostic (6.57e-3)"	"unprognostic (3.33e-1)"	"unprognostic (6.41e-2)"	"unprognostic (4.57e-4)"	"unprognostic (8.97e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.06e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.49e-1)"	1.8	1.6	8.3	0.7	8.2	6.0	1.8	4.2	13.3	2.1	2.3	1.7	0.9	1.9	3.4	5.0	2.7	1.3	3.6	11.1	3.1	2.7	2.0	2.1	0.6	2.7	3.9	3.3	4.9	4.0	7.0	1.4	3.9	2.3	0.9	3.8	7.3	2.3	2.1	3.9	1.3	1.8	2.0	4.1	2.3	0.9	6.6	4.1	5.8	2.1	1.1	2.5	3.3	11.5	2.1	4.3	13.2	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.3	1.7	0.0	2.6	0.0	2.7	0.2	7.4	1.2	0.0	0.0	5.9	0.0	12.7	0.1	0.0	0.8	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.5	0.0	1.8	0.0	0.6	0.0	0.1	16.8	0.0	0.6	0.1	4.8	0.0	3.1	4.1	6.8	15.8	3.2	0.0	0.0	4.7	0.2	0.4	0.0	0.0	2.8	0.0	0.1	0.1	3.8	2.1	0.6	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	8.2	4.2	13.3	11.1	3.1	2.7	3.9	3.9	2.0	6.6	11.5	12.7	12.8	22.1	39.2	0.4	4.2	6.0	3.7	8.6	28.2	3.8	4.6	20.7	5.7	8.7	7.3	0.0	2.7	0.0	0.2	3.9	5.4	1.2	7.2	0.7	18.5	1.8	0.0	181.7	3.1	2.1	5.8	3.1	3.7	0.0	0.3	21.4	5.6	1.1	33.7	192.3	0.4	2.0	2.2	1.5	2.6	0.6	0.8	1.8	72.1	0.0	12.4	0.0	91.0	153.5	2.1	0.0	4.5	1.3	5.2	0.0	4.0	16.8	3.4	0.0	4.8	4.5	0.6	2.0	17.8	3.3	0.7	0.7	3.6	0.4	3.4
TET1	"bA119F7.1, CXXC6, KIAA1676, LCX"	ENSG00000138336	"Tet methylcytosine dioxygenase 1"	Q8NFU7	10	68560337-68694487	"Cancer-related genes, Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Transcription factors"	"Transcription, Transcription regulation"	"Activator, Chromatin regulator, Dioxygenase, DNA-binding, Oxidoreductase, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.5;Extravillous trophoblasts: 79.9;Oligodendrocyte precursor cells: 44.7;Oligodendrocytes: 45.3;Theca cells: 43.7"	"Cancer enriched"	"Detected in some"	15	"testis cancer: 10.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 17.7;HAP1: 20.4;K-562: 12.0;NTERA-2: 11.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019032, HPA057273"			Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm	"Nuclear membrane"	"HPA019032: AB_1847363, HPA057273: AB_2683391"	"unprognostic (1.60e-1)"	"unprognostic (8.30e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.27e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.60e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.00e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.83e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.18e-3)"	"unprognostic (2.88e-4)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.52e-3)"	0.4	0.2	0.6	0.2	1.2	0.3	0.4	4.9	0.7	0.7	0.8	0.4	0.1	0.9	0.6	0.2	0.5	0.3	0.3	0.3	0.9	0.3	0.2	0.2	0.3	0.9	1.3	0.8	0.2	0.7	0.3	1.2	1.1	0.6	0.3	1.5	1.0	0.3	0.9	0.3	0.2	0.5	1.0	0.3	0.4	0.2	1.1	2.0	0.5	0.3	0.3	0.2	0.4	2.2	0.7	0.8	8.0	9.0	0.8	0.7	17.7	0.4	1.0	0.7	1.2	5.5	0.3	0.0	0.3	0.8	0.1	0.0	20.4	0.0	0.8	0.3	3.3	2.1	0.0	4.9	1.2	1.9	1.0	1.0	0.1	0.5	0.1	1.6	0.1	3.5	12.0	1.4	0.7	0.6	3.3	1.4	11.9	0.0	1.1	3.2	2.5	0.2	0.4	0.8	2.2	3.5	0.4	0.5	1.6	7.9	1.0	1.5	0.3	0.7	1.6	0.0	0.6	0.5	0.6	3.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.4	0.3	0.1	0.2	0.0	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.5	0.0	0.6	1.2	4.9	0.7	0.3	0.9	0.9	1.3	1.1	1.0	1.1	2.2	6.3	3.2	6.2	54.5	2.5	1.1	1.8	0.4	5.2	2.5	7.0	9.5	7.2	1.5	2.6	0.0	10.4	21.0	3.0	0.2	0.0	2.7	0.8	3.6	34.2	4.8	13.8	2.5	15.6	0.4	79.9	15.4	1.5	2.9	0.0	13.6	5.7	2.5	3.9	35.3	20.6	0.3	4.1	0.0	0.3	1.7	25.7	0.8	1.8	12.2	0.4	16.1	5.2	44.7	45.3	0.6	0.0	20.7	7.3	1.4	0.0	0.9	0.8	12.5	6.6	21.9	10.7	0.5	1.5	0.8	1.1	27.9	2.6	43.7	0.6	0.4
TF	"PRO1557, PRO2086"	ENSG00000091513	Transferrin	P02787	3	133746040-133796641	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Ion transport, Iron transport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"liver: 7525.8;retina: 2433.0"	"Group enriched"	"Detected in many"	9	"Hepatocytes: 7205.2;Muller glia cells: 12965.3"	"Cancer enriched"	"Detected in many"	42	"liver cancer: 783.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	48	"Hep G2: 780.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001527, HPA005692, CAB009538"	Enhanced				"Secreted to blood"	NA	NA	19800000000000	98000000000	"Cluster 17: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"			"CAB009538: AB_793365, HPA001527: AB_1080357, HPA005692: AB_1080354"	"prognostic favorable (4.05e-4)"	"unprognostic (2.45e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.18e-2)"	"unprognostic (6.63e-2)"	"unprognostic (8.46e-2)"	"unprognostic (2.82e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.60e-2)"	"prognostic unfavorable (2.35e-13)"	"unprognostic (2.17e-3)"	"unprognostic (5.49e-2)"	"unprognostic (3.47e-3)"	"unprognostic (9.70e-2)"	80.9	1.2	186.3	1.0	412.5	2.4	13.3	591.8	274.2	2.0	58.9	2.3	0.9	1.7	1.4	11.0	1.4	1.9	12.1	173.7	287.7	3.4	7525.8	1.9	1.3	786.9	385.4	2.1	4.6	2.2	4.4	1.3	628.2	5.4	1.2	2433.0	55.8	1.8	2.1	4.2	1.6	1.5	484.9	2.9	1.9	14.3	398.1	1.2	2.2	2.7	3.0	1.2	2.8	862.1	1.9	1.4	1.8	1.2	5.5	3.4	0.9	1.9	2.0	1.0	0.8	3.4	1.5	1.7	1.6	1.8	1.2	2.1	1.3	1.8	1.5	1.1	0.7	16.3	2.7	780.9	1.3	4.6	2.7	2.4	3.8	1.0	1.7	1.8	2.2	0.9	6.4	2.1	2.6	1.3	1.1	1.2	1.2	1.2	1.8	1.5	2.9	1.2	1.1	3.1	1.9	1.4	2.4	2.6	7.0	1.3	1.9	1.3	2.9	2.4	1.5	1.6	1.1	1.7	3.0	1.4	2.0	1.5	1.6	0.6	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.1	0.1	0.1	0.0	0.0	186.3	412.5	591.8	274.2	173.7	287.7	786.9	385.4	628.2	484.9	398.1	862.1	0.7	16.0	32.4	36.2	11.4	1.0	5.6	0.6	0.0	101.3	5.3	4.3	2.7	117.2	22.9	0.0	91.8	0.2	0.2	0.1	1.9	0.7	5.4	0.8	1.0	16.7	0.0	56.2	34.2	1.1	0.3	3.9	0.0	0.6	17.7	1.3	87.4	7205.2	0.1	47.1	34.7	0.0	0.0	124.7	0.3	3.8	0.3	4.7	0.0	9.4	0.6	12965.3	0.0	45.2	1077.2	1.1	0.0	0.4	0.0	18.7	0.0	0.5	22.1	400.4	0.0	11.6	0.4	0.5	0.4	3.6	0.0	0.3	7.8	0.5	0.0	3.0
TLCD5	"MGC17839, TMEM136"	ENSG00000181264	"TLC domain containing 5"	Q6ZRR5	11	120325296-120333686	"Predicted membrane proteins"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 51.9"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 28.3;Cytotrophoblasts: 10.0;Extravillous trophoblasts: 4.2;Fibroblasts: 6.1;Syncytiotrophoblasts: 9.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 2.2"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074432			Approved	Vesicles,Cytosol		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"	Vesicles	Cytosol	"HPA074432: AB_2686689"	"unprognostic (1.02e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (6.65e-4)"	"unprognostic (1.65e-2)"	"unprognostic (3.31e-2)"	"unprognostic (6.81e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.86e-3)"	"unprognostic (2.39e-1)"	"unprognostic (2.71e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.28e-2)"	4.4	13.1	11.3	1.0	15.2	0.2	3.3	13.4	10.9	5.0	8.8	2.8	0.6	5.1	7.6	1.5	5.7	3.2	11.0	10.9	12.1	3.6	0.8	4.8	1.4	12.3	15.3	7.7	3.9	4.5	7.0	7.2	12.0	4.9	1.1	51.9	2.0	3.3	1.2	1.3	1.9	3.8	11.3	2.6	2.5	3.1	12.6	0.8	5.4	1.9	1.4	3.5	3.5	14.0	2.4	6.0	15.8	10.9	10.9	16.8	3.0	5.0	12.3	8.4	12.7	3.2	10.2	0.0	15.3	3.2	16.2	1.6	10.1	3.8	9.8	0.0	6.3	8.1	6.1	5.4	12.4	0.0	0.0	14.7	2.8	11.4	17.0	19.7	9.2	9.5	2.2	14.8	10.9	2.9	0.0	0.1	5.1	0.6	3.8	6.3	4.9	0.8	10.4	2.2	8.3	7.2	7.3	0.9	1.5	13.4	9.3	0.2	6.9	8.7	9.0	2.0	3.1	0.2	0.0	0.0	2.6	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.4	0.0	11.3	15.2	13.4	10.9	10.9	12.1	12.3	15.3	12.0	11.3	12.6	14.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	0.0	0.0	0.0	0.0	10.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	4.2	6.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	9.4	0.0	0.0	0.0	0.0
TMEM132A	"FLJ20539, GBP, HSPA5BP1"	ENSG00000006118	"Transmembrane protein 132A"	Q24JP5	11	60924460-60937159	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 187.8;choroid plexus: 117.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.3;Ductal cells: 80.0;Horizontal cells: 254.1;Muller glia cells: 188.8;Rod photoreceptor cells: 165.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 174.1;MCF7: 177.8;SK-BR-3: 176.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051979, HPA060492"	Enhanced	Supported	Approved	Mitochondria		No	No		4100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA051979: AB_2681681, HPA060492: "	"unprognostic (2.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.98e-5)"	"unprognostic (7.94e-3)"	"unprognostic (3.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (1.55e-9)"	"unprognostic (3.31e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.41e-3)"	7.7	21.0	137.9	8.6	134.3	0.3	7.7	119.4	187.8	12.0	117.3	5.5	2.5	13.6	1.2	19.5	4.8	5.5	13.7	134.1	136.9	13.9	2.1	10.1	1.7	154.5	131.2	18.8	6.8	12.4	23.6	16.6	126.4	9.4	1.0	28.1	25.9	1.8	3.9	6.1	6.0	3.7	123.0	5.7	32.4	6.7	144.6	1.3	4.8	3.1	5.4	4.2	9.2	114.7	37.0	50.7	44.1	88.0	3.6	1.7	78.1	27.0	84.5	24.6	20.3	18.0	33.3	0.3	174.1	7.8	79.9	67.6	10.3	46.0	9.5	0.5	14.8	1.1	33.3	32.7	30.8	0.5	1.3	7.7	8.6	45.8	7.1	38.7	42.1	7.0	2.3	2.3	7.8	177.8	0.9	0.2	58.5	1.2	26.9	0.4	18.6	4.2	36.4	18.7	43.7	104.1	19.3	176.4	16.7	22.3	123.7	0.6	49.4	9.5	43.2	2.7	52.3	0.4	0.3	2.1	78.5	0.1	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	137.9	134.3	119.4	187.8	134.1	136.9	154.5	131.2	126.4	123.0	144.6	114.7	11.8	0.0	0.0	82.3	0.6	1.3	2.7	56.2	5.7	62.8	17.1	11.7	0.8	4.3	22.2	5.5	18.8	31.4	0.1	0.7	1.9	80.0	0.5	12.4	7.0	11.9	15.6	0.0	22.6	13.3	28.7	7.7	9.2	27.7	0.0	57.5	11.4	0.0	3.3	254.1	29.1	2.7	20.3	0.3	1.0	1.0	1.8	0.7	0.0	7.5	3.1	188.8	0.0	12.1	3.3	63.2	1.6	3.4	0.0	9.7	0.0	0.4	4.0	165.3	6.6	4.4	15.2	1.2	4.0	5.7	0.9	27.1	0.3	19.2	2.3	7.2
TNFRSF19	"TAJ, TAJ-alpha, TRADE, TROY"	ENSG00000127863	"TNF receptor superfamily member 19"	Q9NS68	13	23570370-23676104	"Plasma proteins, Predicted membrane proteins"	Apoptosis	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 55.3;skin 1: 107.5"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 62.2;Microglial cells: 71.2;Respiratory ciliated cells: 62.4;Suprabasal keratinocytes: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 46.5;BJ hTERT+: 73.2;fHDF/TERT166: 55.9;Hep G2: 83.0;SK-MEL-30: 128.4;WM-115: 76.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010135			Approved	Nucleoplasm,Mitochondria		No	No			"Cluster 35: T-regs - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 28: Keratinocytes - Keratinization"	Mitochondria	Nucleoplasm	"HPA010135: AB_1079797"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.86e-3)"	"unprognostic (2.01e-2)"	"prognostic favorable (3.87e-4)"	"unprognostic (3.74e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.41e-2)"	"unprognostic (6.56e-2)"	"prognostic favorable (9.13e-7)"	"unprognostic (3.44e-2)"	"unprognostic (6.05e-2)"	"unprognostic (3.25e-3)"	"unprognostic (5.38e-3)"	1.8	2.9	1.8	0.9	1.7	1.7	9.9	1.8	1.9	7.0	4.2	2.4	1.8	8.6	13.4	9.4	30.5	3.4	22.1	2.0	2.5	15.7	1.1	17.2	0.7	3.3	3.2	2.7	2.8	0.9	8.5	8.4	2.6	27.4	1.9	4.7	55.3	7.6	2.4	107.5	1.3	3.0	3.1	5.1	5.4	2.2	2.7	6.7	3.4	2.1	1.8	4.5	4.8	2.5	0.1	3.3	3.2	0.0	4.7	46.5	3.5	3.7	73.2	2.0	2.8	23.6	0.1	0.0	0.0	55.9	0.5	0.1	3.3	2.9	3.6	0.0	2.9	0.6	2.4	83.0	2.2	0.2	0.9	22.5	0.7	23.1	0.3	1.5	0.1	0.0	0.1	0.0	13.2	1.1	0.0	0.1	2.3	29.7	5.1	0.0	13.6	0.0	8.4	0.4	30.9	4.9	0.1	0.0	128.4	3.4	0.0	0.3	0.0	11.5	0.5	0.1	3.5	0.0	0.1	0.0	4.5	0.1	76.2	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.2	1.3	0.0	1.8	1.7	1.8	1.9	2.0	2.5	3.3	3.2	2.6	3.1	2.7	2.5	3.1	0.0	20.8	1.0	0.2	62.2	3.0	2.0	23.9	0.8	6.3	2.9	23.4	2.8	9.3	9.2	8.4	0.1	0.3	0.1	0.0	11.1	1.7	10.4	4.4	5.1	0.0	0.0	6.9	1.0	0.0	14.4	2.6	3.9	1.3	0.5	0.0	0.5	0.1	0.0	6.7	0.0	6.1	0.0	8.5	1.0	11.5	0.2	14.2	71.2	0.0	3.3	0.0	12.5	1.1	11.3	0.0	13.9	0.0	13.3	0.0	20.9	62.4	3.3	0.0	3.2	4.9	1.5	2.3	8.3	80.3	0.0	0.6	3.5	0.0	0.6
TPPP3	"CGI-38, p20, p25gamma"	ENSG00000159713	"Tubulin polymerization promoting protein family member 3"	Q9BW30	16	67389809-67393518	"Predicted intracellular proteins"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 858.4"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 962.0;Melanocytes: 501.6;Respiratory ciliated cells: 1825.2;Suprabasal keratinocytes: 495.3"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 61.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 65.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 59.9;OE19: 40.8;RH-30: 31.1;SCLC-21H: 47.8;SH-SY5Y: 20.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047629, HPA061691"	Enhanced		Approved	"Nucleoli fibrillar center"		NA	NA		43000	"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"		"HPA047629: AB_2680108, HPA061691: "	"unprognostic (1.63e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.35e-1)"	"unprognostic (7.28e-3)"	"unprognostic (4.48e-3)"	"unprognostic (1.59e-3)"	"unprognostic (9.22e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (3.51e-2)"	"unprognostic (9.44e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.86e-3)"	44.3	27.1	199.2	8.0	200.1	1.0	81.0	186.0	225.7	50.3	168.7	96.4	23.7	29.3	9.7	99.3	858.4	21.9	81.4	188.1	222.0	60.7	4.4	148.0	4.4	258.7	291.6	8.6	23.9	13.6	40.7	78.5	231.2	18.9	14.1	9.6	39.5	13.3	72.2	170.5	38.0	21.4	223.6	17.7	43.6	15.4	228.3	4.7	18.4	55.8	9.1	32.8	36.4	296.2	0.4	59.9	0.6	0.4	0.4	9.4	0.2	1.7	0.4	0.4	0.9	3.9	12.0	0.0	0.9	0.8	0.2	11.3	9.2	0.0	0.1	0.0	3.5	0.0	1.5	1.7	0.1	0.0	0.0	2.4	0.3	3.6	0.0	1.8	0.6	0.0	0.1	0.0	5.4	0.3	0.0	0.2	1.9	40.8	0.0	0.0	31.1	0.2	0.0	0.0	47.8	20.7	0.0	0.1	2.4	1.5	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.1	0.0	0.0	2.9	0.0	0.9	0.0	25.4	12.4	0.0	37.6	0.2	0.0	0.0	0.0	33.1	0.1	0.0	0.0	5.8	0.0	65.8	0.3	0.0	9.4	199.2	200.1	186.0	225.7	188.1	222.0	258.7	291.6	231.2	223.6	228.3	296.2	14.7	16.0	129.8	17.0	0.2	303.9	8.8	92.5	5.7	3.8	5.9	5.0	4.1	30.0	160.4	18.4	4.2	8.3	0.2	28.4	5.9	166.8	60.1	962.0	30.9	31.6	177.9	0.0	0.5	1.8	4.3	141.9	7.1	14.7	25.4	1.0	5.0	0.1	2.9	0.0	0.7	65.1	132.2	3.8	82.5	23.7	29.2	13.7	501.6	1.0	10.7	68.7	1.0	1.0	30.0	8.4	39.7	3.4	0.0	5.6	29.8	0.9	1825.2	8.9	236.7	259.3	163.7	8.1	5.8	1.6	495.3	80.0	5.5	0.8	27.3	10.1
TRABD2B	TIKI2	ENSG00000269113	"TraB domain containing 2B"	A6NFA1	1	47760528-47997385	"Predicted intracellular proteins"	"Wnt signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 16.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 7.5;Cholangiocytes: 15.7;Fibroblasts: 6.6;Hepatocytes: 11.3;Microglial cells: 7.5;Proximal tubular cells: 22.8"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 12.8"	"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HeLa: 6.7;U-2197: 13.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			HPA045817	Approved				"Intracellular and membrane"	NA	NA		41000		"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA045817: AB_2679460"	"unprognostic (2.38e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.26e-2)"	"unprognostic (5.65e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.29e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.41e-2)"	"unprognostic (4.77e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.67e-1)"	2.3	0.9	0.1	0.6	0.2	0.0	2.7	1.0	0.3	2.8	0.5	2.9	0.4	1.5	0.8	1.3	1.9	1.6	7.0	0.1	0.0	16.6	4.2	1.7	0.0	0.1	0.2	0.8	2.6	0.0	1.5	0.4	0.2	3.6	0.7	0.0	1.6	3.3	0.6	1.6	1.6	0.9	0.1	1.2	1.6	0.9	0.1	0.4	1.0	0.6	0.1	3.8	2.6	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	1.2	0.0	6.7	0.0	0.6	0.0	0.0	0.0	0.2	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	1.4	13.2	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.0	0.3	0.1	0.0	0.1	0.2	0.2	0.1	0.1	0.2	1.6	0.0	0.5	0.3	0.3	0.8	1.4	0.6	2.8	0.0	0.6	2.9	7.5	15.7	0.1	1.8	0.0	0.0	0.0	0.0	5.9	3.8	0.1	0.1	0.5	1.9	0.0	0.0	0.3	2.2	0.0	6.6	0.0	0.1	0.0	0.0	1.4	11.3	0.1	0.0	0.3	0.1	0.0	0.0	0.9	0.3	0.0	0.3	0.0	7.5	0.0	0.0	0.0	0.5	0.7	1.3	0.0	2.2	0.1	0.4	0.0	22.8	0.0	0.0	0.0	0.3	4.1	0.0	4.0	0.1	0.3	0.0	0.2	0.1	0.0	0.2
WIPF1	"WASPIP, WIP"	ENSG00000115935	"WAS/WASL interacting protein family member 1"	O43516	2	174559572-174682916	"Disease related genes, Human disease related genes, Predicted intracellular proteins"		Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 126.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 172.7;monocytes: 187.2;NK-cells: 245.1;Oligodendrocytes: 217.2;Plasma cells: 162.8;T-cells: 208.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 209.1;Karpas-707: 296.8;U-266/70: 233.0"	"Low region specificity"	"Detected in all"							"HPA003739, CAB009737, HPA070706"	Enhanced		Approved	"Plasma membrane,Cytosol"		No	No		520000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol	"Plasma membrane"	"CAB009737: AB_2288577, HPA003739: AB_1858783, HPA070706: AB_2686300"	"unprognostic (4.76e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.49e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.27e-3)"	"unprognostic (2.05e-1)"	"unprognostic (1.21e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (1.14e-4)"	"unprognostic (3.65e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.50e-2)"	31.0	14.7	14.2	93.0	37.2	56.8	21.0	36.1	20.5	30.6	11.1	26.0	18.2	22.4	11.5	14.2	14.4	34.8	16.0	14.9	28.8	13.0	16.4	31.8	126.9	46.2	38.6	12.3	7.3	12.9	4.8	33.5	42.3	14.9	20.8	3.4	17.7	23.0	5.9	9.9	32.5	29.1	27.9	89.7	21.8	4.7	35.1	66.4	15.4	11.5	110.5	31.5	17.0	53.8	0.7	7.0	16.3	0.2	40.4	70.9	16.9	31.1	26.4	12.1	18.7	1.9	1.4	209.1	9.2	47.0	15.6	0.5	2.8	0.0	15.1	144.8	4.1	106.5	26.9	0.0	15.1	94.9	167.2	29.6	5.1	27.7	2.6	16.0	25.0	18.7	3.3	296.8	34.4	0.1	106.6	87.1	19.1	0.0	1.4	90.0	6.6	37.9	11.3	0.7	2.6	33.8	0.3	8.8	18.7	30.4	0.4	46.8	21.2	41.0	11.5	30.1	29.9	233.0	165.2	113.7	60.4	64.7	111.7	41.5	35.4	87.2	71.6	37.3	59.4	35.1	47.6	71.1	26.1	28.6	38.0	51.4	166.1	57.4	43.7	11.2	57.7	54.7	14.2	37.2	36.1	20.5	14.9	28.8	46.2	38.6	42.3	27.9	35.1	53.8	32.1	19.2	21.7	27.7	134.5	12.5	6.3	0.9	2.8	2.1	3.3	4.3	10.5	1.5	4.6	3.7	25.0	2.0	172.7	0.3	5.9	1.7	40.2	3.3	21.9	30.8	4.9	30.1	5.3	11.6	82.5	40.5	9.7	2.1	67.2	2.1	36.8	3.7	86.2	0.0	7.2	1.6	0.0	142.2	128.0	96.9	25.1	139.8	26.6	98.4	187.2	1.2	245.1	120.6	217.2	16.8	0.8	18.0	162.8	5.0	0.2	35.9	0.1	3.4	13.1	15.7	21.4	4.4	4.1	1.2	11.1	4.1	208.1	8.8	2.1	3.1
WNT16		ENSG00000002745	"Wnt family member 16"	Q9UBV4	7	121325367-121341104	"Predicted intracellular proteins, Predicted secreted proteins"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix: 6.0;skin 1: 20.5"	"Cell type enhanced"	"Detected in some"		"B-cells: 4.6;Basal keratinocytes: 10.1;Endometrial stromal cells: 3.6;Inhibitory neurons: 6.0;Microglial cells: 3.7;Plasma cells: 2.6;Suprabasal keratinocytes: 11.5"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	145	"memory B-cell: 15.6;naive B-cell: 15.4"	"Lineage enriched"	"Detected in single"	146	"B-cells: 15.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 2.3;HEK 293: 5.4;hTEC/SVTERT24-B: 1.6;U-2197: 2.6;U-266/70: 1.6"	"Low region specificity"	"Detected in single"			"Region enhanced"	"Detected in some"		"spinal cord: 4.4"						"Secreted to extracellular matrix"	NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 61: Skin - Cornification"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (6.53e-2)"	"unprognostic (3.63e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.90e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.77e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.57e-10)"	"unprognostic (5.89e-3)"	"unprognostic (2.73e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.66e-1)"	0.2	0.3	0.3	0.3	0.6	0.0	1.4	0.2	0.4	6.0	0.5	0.5	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.4	0.2	0.1	0.2	0.3	1.1	0.2	0.2	0.0	0.1	0.0	0.3	0.4	0.1	0.6	0.1	0.1	0.1	1.8	0.1	20.5	0.5	0.2	0.3	0.8	0.2	0.1	0.0	0.1	0.1	0.0	0.4	0.1	3.2	0.2	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.2	0.0	0.5	0.1	0.5	0.0	0.0	0.0	0.0	5.4	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.3	1.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	15.6	0.0	0.0	0.0	15.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.3	0.6	0.2	0.4	0.4	0.2	0.2	0.2	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	4.6	10.1	0.1	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	3.6	0.1	0.0	0.4	0.1	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	6.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	3.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	11.5	0.0	0.1	0.0	0.1	0.0